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ABSTRACT
In the novel diamond-like carbon polymer hybrid (DLC-p-h) coatings, the useful 
properties of diamond-like carbon (DLC) and a chosen polymer can be combined. So far 
two unique biomaterials, diamond-like carbon polytetrafluoroethylene hybrid (DLC-
PTFE-h) and diamond-like carbon polydimethylsiloxane hybrid (DLC-PDMS-h) with 
dirt-repelling hydrophobic and oleophobic properties have been developed. These novel 
coatings were studied in this thesis.
The Diamond Group at the ORTON Research Institute have produced novel 
biomaterial coatings with the in-house developed Filtered Pulsed Arc Discharge (FPAD)-
method. The FPAD method enables the production of thick (>200 μm), high quality (> 
80% diamond sp3 –bonds) DLC coatings with properties needed in high-load bearing 
applications such as the Total Hip Arthroplasty (THA). 
Bacterial adhesion is the initial step in the prosthetic joint infection (PJI) and leads to 
biofilm formation and the establishment of a full-scale deep biofilm infection.  The main 
hypothesis was that some biomaterials, such as DLC and non-fouling DLC-PDMS-h and 
DLC-PTFE-h, could be more resistant to bacterial adhesion and biofilm formation than 
the conventional implant materials. To mimic conditions prevailing in the human body, 
serum incubations, and dynamic flow conditions are useful in the investigation of bacterial 
adhesion and biofilm formation in vitro. 
Under static conditions and in the presence of serum proteins, the DLC was more 
microbe-repellent than conventional biomaterials tantalum, titanium, and chromium and 
resisted the most the adhesion of S.aureus cells. In this study, it was also found that 
micropatterned surfaces are useful for quantitative evaluation of bacterial adhesion to 
biomaterials. Different sizes of microtextures enabled data collection regarding alignment 
of bacteria on sample surfaces.
Under dynamic flow conditions, DLC and DLC-PTFE-h were as good as conventional 
biomaterials in their ability to inhibit adhesion of S.aureus and S.epidermidis. The DLC-
PDMS-h bound significantly more S.aureus bacteria than DLC-PTFE-h and tantalum. 
Otherwise, the DLC-PDMS-h behaved similarly to the other materials tested.  
Biofilm formation was examined in the presence of serum. The DLC-PTFE-h was 
superior compared to all materials tested in its ability to resist biofilm formation. The DLC 
came out next in the ranking order and resisted biofilm formation soundly compared to 
conventional biomaterials and DLC-PDMS-h. The DLC-PDMS-h was similar to 
conventional materials in its ability to inhibit biofilm formation. 
Antimicrobial peptides (AMPs) are defense proteins of innate immunity found widely 
in plants, vertebrates, and non-vertebrates with multiple functions even beyond immunity.  
??????????????????????????????????????????????????-defensin-3 (hBD-3) in septic joint 
implant loosening were examined by immunohistochemistry and double 
immunofluorescence stainings of peri-implant tissue samples. hBD-3 was associated with 
monocyte/macrophage-like cells, fibroblast-like cells, and vascular endothelial cells. It 
was weakly present in foreign body giant cells and not found in neutrophils. The variable 
topological expression of hBD-3 in peri-implant tissues in septic implant loosening 
indicated local induction, as has been reported in the literature before. 
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In summary, the three studies of this thesis suggest that DLC and DLC-PTFE-h
coatings could inhibit bacterial adhesion and subsequent biofilm formation, thus 
preventing infections more efficiently than current implant biomaterials. The cellular 
sources of the antimicrobial peptide hBD-3 in peri-implant tissues in septic implant 
loosening are mainly macrophages and vascular endothelial cells.
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TIIVISTELMÄ
Lonkkanivelen pitkälle edennyttä nivelrikkoa sekä muita sairaustiloja hoidetaan 
lonkan tekonivelleikkauksella joka on yksi selkeimmin elämänlaatua parantavista 
kirurgisista toimenpiteistä. Ikääntyvien ihmisten määrän kasvaessa sekä 
leikkausindikaatioiden laajentuessa nuorempiin ja aktiivisempiin potilaisiin, implanttien 
tarve jatkuvasti lisääntyy. Vaikka nykyiset kirurgiset tekniikat sekä leikkaushygienian 
toteutus ovat pitkälle kehittyneet, tekonivelinfektioita esiintyy 0.5-1.2% ensimmäistä 
kertaa leikatuista ja uusintaleikkausten jälkeen useammin. Leikkauksen jälkeinen 
proteesi-infektio on edelleen merkittävä komplikaatio terveydenhuoltojärjestelmässä ja 
kyseiselle potilaalle luonnollisesti katastrofi johon liittyy huomattavaa kärsimystä, 
sairastavuutta ja jopa kuolleisuutta. Tekonivelinfektio vaatii usein pitkän 
antibioottihoidon sekä teknisesti vaativia uusintaleikkauksia parantuakseen. 
Uusintaleikkauksiin liittyy huomattavia kustannuksia ja pitkiä sairaalahoitojaksoja eikä 
lopputulos useinkaan vastaa odotuksia. Kasvava antibioottiresistenssi huomioon ottaen 
ehdotetaan, että optimaalinen tapa ehkäistä näitä infektioita olisi käyttää bakteerien 
adheesiota sekä biofilmin muodostumista hylkiviä implanttimateriaaleja sekä pinnoitteita. 
Timantinkaltaisen hiilen (DLC) ja polymeerien hyödylliset ominaisuudet voidaan 
yhdistää hiili-polymeeri-hybridipinnoitteissa (diamond-like carbon polymer hybrid eli 
DLC-p-h). Tähän mennessä on kehitetty kaksi ainutlaatuista timantti-muovi-
hybridipinnoitemateriaalia: timantti-polytetrafluoroetyleeni-hybridipinnoite (DLC-PTFE-
h) sekä timantti-polydimetyylisiloksaani-hybridipinnoite (DLC-PDMS-h). Edellisessä 
timantti on siis yhdistetty tefloniin ja jälkimmäisessä silikoniin. Näitä likaa, vettä sekä 
öljyä hylkiviä hybridipinnoitteita tutkittiin väitöskirjassa.
Tieteellinen Tutkimus Ortonin Timanttiryhmä on valmistanut nämä uudet 
biomateriaalipinnoitteet itse kehittämällään kaaripurkausmenetelmällä. Kyseisellä 
menetelmällä valmistetaan myös paksuja sekä korkealaatuisia timantinkaltaisia 
hiilipinnoitteita (timanttipinnoitteita). Näitä timanttipinnoitteita voidaan käyttää 
sovelluksissa, joissa tarvitaan korkeaa kuormituskestävyyttä, kuten lonkan tekonivelissä.
Proteesi-infektion ensimmäinen vaihe on bakteerien adheesio eli tarttuminen 
biomateriaalin pintaan. Tämä tapahtuu lähes välittömästi kun materiaali tuodaan nesteisen 
bakteeripitoiseen ympäristöön. Bakteeri adheesio johtaa biofilmin muodostumiseen ja 
mahdollistaa täysimittaisen syvän biofilmi-infektion kehittymisen. Väitöskirjan 
päähypoteesina oli, että jotkut biomaterialit, kuten DLC sekä DLC-PDMS-h ja DLC-
PTFE-h, ovat vastustuskykyisempiä bakteerien adheesiolle ja biofilmin muodostumiselle 
verrattuna perinteisiin implanteissa käytettäviin biomateriaaleihin. Tutkittaessa bakteerien 
adheesiota sekä biofilmin muodostumista laboratorio-olosuhteissa (in vitro), on 
hyödyllistä käsitellä materiaalit ensin seerumilla sekä toteuttaa tutkimus virtaavassa 
nesteessä käyttäen dynaamista virtausmallinnusta. Nämä menetelmät vastaavat paremmin 
ihmiselimistössä vallitsevia olosuhteita (in vivo) jossa kudosnesteet harvoin ovat 
liikkumattomia ja biomateriaalit pinnoittuvat välittömästi seerumilla ennen ensimmäistä 
bakteerikontaktia.
Väitöskirjatutkimuksessa todettiin että staattisissa olosuhteissa seerumikäsittelyn 
jälkeen DLC hylki mikrobeja paremmin kuin tavalliset biomateriaalit tantaali, titaani sekä 
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kromi ja vastusti parhaiten Staphylococcus aureus bakteerin tarttumista 
biomateriaalipintaan. Tässä työssä nähtiin, että biomateriaalipinnan mikrokuviointi 
helpottaa bakteerien tarttumisen kvantitatiivista analyysia. Erikokoiset mikrokuviot 
mahdollistivat myös tiedon keruun liittyen bakteerien sijoittautumiseen näytepinnoilla.
Dynaamisissa virtausolosuhteissa DLC ja DLC-PTFE-h estivät yhtä hyvin kuin 
tavalliset implanttimateriaalit S. aureus ja Staphyloccous epidermidis bakteerien 
tarttumista. DLC-PDMS-h:n pintaan tarttui merkittävästi enemmän S. aureus bakteereita 
kuin DLC-PTFE-h:n tai tantaalin pintaan. Muutoin se käyttäytyi kuten muut testatut 
materiaalit.
Biofilmin muodostumista tutkittiin seerumin läsnä ollessa. DLC-PTFE-h vastusti 
näissä kokeissa selvästi parhaiten biofilmin muodostumista. Myös DLC vastusti biofilmin 
muodostumista hyvin verrattuna tavallisiin implanttimateriaaleihin sekä DLC-PDMS-h:n
joiden pintaan biofilmi tarttui herkemmin.
Antimikrobiset peptidit ovat luonnollisen immuniteetin puolustusmolekyylejä, joita 
esiintyy kasveissa, selkärankaisissa sekä ei-selkärankaisissa eliöissä. Näillä peptideillä on 
immuniteetin lisäksi muitakin tehtäviä. Ihmisen kudoksissa esiintyy human beta-defensin-
3 (hBD-3) nimistä antimikrobista peptidiä. Tässä väitöskirjassa selvitettiin hBD-3:n 
tuotantoa septiseen nivelimplantin irtoamiseen liittyvissä kudosnäytteissä 
immunohistokemiallisia menetelmiä sekä kaksoisimmunofluoresenssi-värjäystä käyttäen. 
Tutkittavat kudosnäytteet oli otettu implanttia ympäröivästä kudoksesta potilailta, joilla 
oli diagnosoitu septinen nivelproteesin irtoaminen. hBD-3:a löydettiin 
monosyytti/makrofagi-tyyppisistä soluista, sidekudossoluista sekä verisuonten 
endoteelisoluista. Sitä oli heikosti nähtävissä vierasesinejättisoluissa eikä lainkaan 
neutrofiileissä. hBD-3:n vaihteleva topologinen esiintyminen tulehtunutta proteesia 
ympäröivässä kudoksessa viittaa paikalliseen eritykseen, mikä on linjassa aiemman 
kirjallisuuden kanssa.
Kolme tämän väitöskirjan tutkimusta viittaavat, että DLC sekä DLC-
PTFE-h pinnoitteet voivat estää bakteerien tarttumista ja sitä seuraavaa biofilmin 
muodostumista biomateriaalien pinnalla. Tällä tavoin nämä biomateriaalit ehkäisisivät 
infektiota tehokkaammin kuin nykyiset implanttimateriaalit. Antimikrobisen peptidin 
hBD-3:n solulähteet septisessä implantin irtoamisessa ovat pääosin proteesia ympäröivän 
kudoksen makrofagit sekä verisuonten endoteelisolut.
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PE polyethylene
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PJI prosthetic joint infection
PMMA poly (methyl methacrylate)
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SAMs self-assembled monolayers
S.aureus Staphylococcus aureus
SEM scanning electron microscope
S.epidermidis Staphylococcus epidermidis
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Ta tantalum
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TEM transmission electron microscopy
THA total hip arthroplasty
THR total hip replacement
Ti titanium
TKA total knee arthroplasty
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VRE vancomycin-resistant Enterococcus faecium
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?? contact angle 
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??? dispersive component of the surface free 
energy of the solid
??? dispersive component of the surface free 
energy of the liquid
? electrolyte viscosity
 ??? liquid-vapor interfacial energy
??? polar component of the surface free energy of 
the solid
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??? polar component of the surface free energy of 
the liquid
? shear rate
??
?? slope of streaming current versus pressure
??? solid-liquid interfacial energy
??? solid-vapor interfacial energy
?? total surface free energy of the solid
?? total surface free energy of the liquid
?? vacuum permittivity
? zeta potential
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1. INTRODUCTION 
The use of different medical devices and implants in patient care is an important way 
to support the quality of life and satisfactory functioning health. An implant is a human-
made medical device that is used to enhance an existing biological structure, support a 
damaged biological structure or replace a missing biological structure. Biomedical 
biomaterials can be applied as a bulk or as coatings on the implants to achieve a proper 
functionality of the device. There is a countless number of these biomedical applications 
available today: artificial hip and knee joint implants, artificial heart valves and 
pacemakers, stents (cardiac catheters), ventilation supporting devices and urinary 
catheters are used widely in the hospitals. The development of technology in materials 
science and progress in research have cemented the position of implantology in the field 
of biomedicine. Ideally, an implant should not cause any undesired reaction from 
neighboring or distant tissues. Nevertheless, complications can occur during or post-
surgery when an invasive device is inserted into the human body. Depending on the type 
of an implant, these complications may vary and include infection, inflammation, pain, 
coagulation and the risk of rejection or loosening. 
Due to the increasing number of aged people, the development of technology and the 
widening of the primary operation indications to include younger and more active patients, 
the use of implants is predicted to grow. Whenever an implant is used in patient care, there 
is a certain risk of infection, as the implant surface offers a platform for microbial adhesion 
and biofilm formation. The risk of an infection varies dependently on the type of the 
implant and location in the human body and is increased with reimplantation (revision). 
Mortality is highest among patients with cardiovascular implants. In this group, 4-40% of 
initially inserted implants become infected (Darouiche,RO. 2004). Although the risk of 
infection associated with primary total hip arthroplasty (THA) is rather low, the total 
number of THA operations being done is rising markedly. For those 1% of the primary 
THAs concerned with a prosthetic joint infection (PJI), it is a catastrophic condition 
associated with patient suffering, significant morbidity, and even mortality (Jamsen,E, et 
al. 2010). In revision surgery, the incidence of infection is higher, estimated to be 3.2-
5.6% in both hips and knees (Montanaro,L, et al. 2011). The enormous economic impact 
of these infections is seen in increased costs of repeated surgical operations and in both 
long-lasting hospitalizations and continuing medical care. Each year millions of 
individuals regain functionality due to orthopedic biomaterials what is reflected also in the 
global biomaterials market. Orthopedic biomaterials sales were $24 billion in 2007 with 
an expected growth rate of 7-9% annually (Hallab,N and Jacobs,J. 2013). 
Infections begin with bacterial adhesion. Adhesion is related to the survival of 
microbial species, and the adhesins are among of the most important virulence factors. As 
infection proceeds, a bacterial biofilm is formed. Bacterial biofilm resembles a complex 
ecosystem, in which communities of bacterial cells are embedded in structural glycocalyx 
matrix of polysaccharides, proteins, extracellular DNA (eDNA) and bacterial products 
(Hall-Stoodley,L, et al. 2004). It has been thought that implant infection, also known as 
septic loosening, would be less likely if human tissue cells could adhere and grow on 
biomaterial surface that at the same time could inhibit microbial adhesion (Gristina,AG. 
1987). 
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Currently, strict hygienic protocols are followed and advanced surgical techniques are 
used. Despite extensive research and progresses in treatment and diagnostics, PJI is still a 
significant menace both for patient and society. PJI often necessitates a longer course of 
antibiotical treatment and revision operations. The revision operations require extended 
hospitalizations and are linked to increased health care costs (Kurtz,SM, et al. 2007).  The 
alarming rise of the antibiotic resistance and the adverse effects associated with the 
extensive use of antibiotics underline the urgent need for further solutions.  Therefore, it 
is suggested that the optimal way to combat infections of implants would be to use implant 
materials and coatings able to repel adhesion of bacteria and inhibit biofilm formation. 
New biomaterials intended for use in medical devices should be tested for their anti-
bacterial properties such as their ability to inhibit bacterial adhesion and biofilm 
formation.
Biomaterial characteristics, bacterial properties, environmental and host factors 
determine whether initial bacterial adhesion develops into a full-scale implant infection. 
The diamond-like carbon (DLC) and its novel diamond-like carbon polymer hybrid (DLC-
p-h) coatings produced with the Filtered Pulsed Arc Discharge (FPAD) method are 
promising candidates for utilization in medical implants (Alakoski,E, et al. 2003, 
Anttila,A, et al. 1999, Lappalainen,R, et al. 2003). Up to date, little information is available 
in the literature concerning their interactions with bacteria. This thesis aims to analyze an 
ability of the FPAD-produced DLC and DLC-p-h coatings to repel bacterial adhesion and 
biofilm formation. 
Recent progress in immunology is leading the way for exciting new opportunities in 
therapeutics and diagnostics (Hogan,S, et al. 2015). Antimicrobial peptides are human 
body´s natural antibiotics and could offer an advantage in the diagnosis or treatment of 
implant infections (Batoni,G, et al. 2016, de la Fuente-Nunez,C, et al. 2016, Lee,JK, et al. 
2013, Liu,GD, et al. 2014). The cellular sources of antimicrobial peptides in septic joint 
implant loosening are not well defined yet.
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2. REVIEW OF THE LITERATURE
2.1 Implant materials 
2.1.1 Overview 
An orthopedic implant supports a fractured bone or replaces a part or all damaged, 
malfunctioning joint. As the demand for better quality of life and number of osteoarthritis 
patients increases with longer life expectancy amongst older adults, better, durable and 
long-lasting implants are needed. Particularly in the United States, growing number of 
obese people and sport accidents enhanced the need for high-quality prostheses 
(Stoodley,P, et al. 2013). At the same time, the development of materials science and 
technology allows production of more advanced biomedical devices. Osteoarthritis, 
rheumatoid arthritis, osteoporosis, fracture and congenital abnormalities are possible 
indications for arthroplasty.  Since use of prostheses can be more than 30 years the current 
average life span for total hip implants is not sufficient. As the emphasis in this thesis is 
on orthopedical implant infections, the focus is on biomaterials used in orthopedical 
devices, mostly joint replacements. 
Biomaterials can be classified based on chemical composition (metals, polymers, 
ceramics, composites and materials of biological origin) and based on materials surface
reactivity (inert, with a smooth or a porous surface, chemically reactive surfaces or 
bioresorbable). The classification of biomaterials can also be done on a historical basis. 
The first generation biomaterials emphasize a proper functional performance when 
replacement of body parts is considered, e.g., in load-bearing biomaterials. They have 
minimal tissue-biomaterial interactions. The second generation biomaterials show control 
or induction of favorable host reactions, e.g. bioresorbable materials, which allow in-
growth of host tissues. The third generation biomaterials is associated with the 
regeneration of impaired tissue, tissue engineering products and living cells used in 
combination with artificial materials (Konttinen,YT, et al. 2014).
Orthopedic joint prosthesis materials should maximize wear resistance and fatigue 
strength and minimize stress shielding and material degeneration due to corrosion or 
degradation (Kaivosoja,E, et al. 2012a). DeMane proposed properties of an ideal implant: 
it should be noncarcinogenic, non-allergenic, sterilizable and biocompatible. The material 
should be clinically inert unless it is biodegradable or fabricated for certain activities. It 
should also be structurally stable, not physically modifiable by tissue fluids, and not 
causing inflammatory or foreign body response (DeMane,CQ. 1995).
Biocompatibility is one important property that describes the ability of a material to 
perform with an appropriate host response (Williams,D. 1987). It means that material has 
to perform, not only exist in the tissues, the response created by the material has to be 
appropriate for the application and the nature of the reaction to a particular material, and 
its suitability may vary from one situation to another (Williams,D. 1999). Both bulk and 
material surface characteristics contribute to this biocompatibility, and various chemical, 
biochemical, physiological, physical and other mechanisms affect the outcome 
(Williams,DF. 2008). 
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The THA, also named the operation of the century, has been notably successful due to 
good and predictable long-term results. It started in the 1890s when ivory implants were 
used in arthroplasties (Gluck,T. 1890). The introduction of metal-on-metal (MoM) THAs, 
occurred in the 1930s and later they were developed further in the 1950s and 1960s 
(Wang,W, et al. 2011). The modern low-friction hip arthroplasty era began in the 1970s 
with the hard-on-soft bearing concept, where polyethylene was used in the cup, stainless 
steel in the femoral head and stem, and poly (methyl methacrylate) (PMMA) as bone 
cement (Charnley,J. 1960, Charnley,J. 1979). THA developed by Charnley has been 
successful ever since, with 77% to 81% survivorship at 25-year follow-up reported in first-
generation results of his low friction arthroplasty with the revision of any component as 
the endpoint. Long-term survival in more than 90% of patients over 60 years of age has 
been associated with Charnley´s THA (Berry,DJ, et al. 2002, Callaghan,JJ, et al. 2000, 
Della Valle,CJ, et al. 2004, Wang,W, et al. 2011, Wroblewski,BM, et al. 2007). 
Currently, THA usually uses a titanium or cobalt-chromium alloy femoral stem (press 
fit into place or cemented with PMMA) and a modular cobalt-chrome alloy or ceramic 
head. The head articulates on a ceramic or ultra-high molecular weight polyethylene 
(UHMWPE) acetabular cup fitted into a cobalt-chromium or titanium cup liner that is 
cemented, screwed, or press fitted into place (Hallab,N and Jacobs,J. 2013).
In 2013, there was a total of 22 000 hip and knee arthroplasty operations registered in 
the Finnish National Institute of Health and Welfare (THL, Terveyden ja Hyvinvoinnin 
Laitos) Implant Register of which 48% were hip prostheses and 52% knee prostheses. 
From the year 2000, the number of registered hip-and-knee implants has nearly doubled, 
especially regarding the number of knee implants (Rainio J,PA. 2014).
2.1.2 Metals
2.1.2.1 General properties of metals 
Use of metals in the treatment of fractures started in the nineteenth century with silver 
wires, iron nails and galvanized steel (Peltier,L. 1990). In the 1940s, the first metallic hip 
replacement implant was made of CoCrMo alloy (Vitalium) (Plecko,M, et al. 2012). Later 
on, Co-30Cr-6Mo alloy and stainless steel (SS) became widely used in the main joint 
replacements and internal fixations. 
Metals used as biomaterials in the human body are tightly regulated. Biofunctionality 
must be clarified using clinical trials. International Organization for Standardization 
(ISO), American Society for Testing Materials (ASTM) and other standards together with 
the European Union (EU) /Food and Drug Administration (FDA) guidelines/directives are 
usually used to verify compliance with “the Essential Requirement” and biocompatibility. 
Metals remain nowadays highly used in fracture fixations and total joint arthroplasties 
(TJAs) whenever good load bearing properties are warranted.
Second generation metal- on- metal ( MoM) bearings wear rate has been found to be 
20 to 100 times lower than that of metal-on-traditional polyethylene (Silva,M, et al. 2005). 
Large heads in thin acetabular shells  reduce incidence of hip dislocation in younger and 
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more active patients (Manley,MT and Sutton,K. 2008). Even though the MoM couple has 
biomechanical advantages, the metal ion release has potentially harmful effects. The 
accumulation of metal ions is disadvantage of using the MoM couples (Dobbs,HS and 
Minski,MJ. 1980, Ziaee,H, et al. 2007). Increased dermal hypersensitivity to metals and 
lymphocytic infiltration as a sign of early inflammation with pain has been reported in the 
surrounding tissues (Dumbleton,JH and Manley,MT. 2005, Willert,HG, et al. 2001, 
Willert,HG, et al. 2005). There is also a concern of higher cancer risk and occurrence of 
pseudotumors related to the use of MoM bearings (Willert,HG, et al. 2005). Regarding 
biological reactivity, metal wear debris is thought to be more reactive than ceramic or 
polyethylene debris (Dumbleton,JH and Manley,MT. 2005). The use of MoM bearing 
surface stemmed femoral components has been abandoned in the last years due to high 
failure rates and concerns explained above (Kumar,N, et al. 2014).
2.1.2.2 Stainless steel-based materials
Stainless steel (SS) materials are used in orthopedics in fracture fixation often 
temporarily as medullary nails, plates, screws, pins and steel threads. Disadvantages of 
using SS based materials relate to the release of metal ions and high elastic modulus. 
Released metal ions may cause various adverse effects like chronic inflammation, 
carcinogenesis and cell death and necrosis while high elastic modulus causes stress 
shielding. Wolff´s law states that living bone must be under a certain amount of cyclic 
stress to remodel and stay healthy. If the stress distribution to bones is abnormal, too high 
or too low, the bone will remodel into resorption or absorption. This is called stress 
shielding which can cause weakening of the adjacent bones if the elastic modulus of the 
material is higher than that of bone. 
2.1.2.3 Titanium-based materials
In the 1940s, Ti-based materials started to replace SS and Co-Cr materials in most 
orthopedic implants. Now Ti and Ti alloys are the most widely used materials in the 
orthopedic field. In joint implants, pure titanium is sometimes employed in acetabular 
cups, but usually, TiAl6V4 or sometimes TiAl6Nb7 alloys are used for titanium-based 
acetabular cups and prosthetic stems. As a biocompatible material, titanium has been 
known for its excellent osseointegration capacity since its early days of use in dental 
implants. The use of TiAl6V4 reduces the stress shielding effect and debris generation. 
This is because the modulus of elasticity of TiAl6V4 is closer to cortical bone than that of 
SS or Co-Cr alloys. Ti-based implants can be inserted without bone cement, which is 
typically used with other metallic and SS and Co-Cr materials to improve stress 
distribution to the bone. A peri-implant bone around cementless stems has been shown to 
possess lower risk for osteolysis, and mechanical failure than bone around cemented stems 
(Affatato,S. 2012). The drawback of titanium alloys relates to their softness compared 
with Co-Cr-Mo alloys and also to their relatively poor wear and frictional properties. For 
this reason, titanium alloys are rarely used when hardness or wear resistance is considered 
to be the optimal property. There has even been a discussion about the link between 
aluminum (Al) ions released from Ti alloys and Alzheimer’s disease, but no conclusive 
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evidence has been yet provided (Frisardi,V, et al. 2010, Konttinen,YT, et al. 2014, 
Landsberg,JP, et al. 1992).
2.1.2.4 Chromium-cobalt-based materials
Cobalt-based alloys are used for stems, and as hard metals in the metal head (balls). 
CoCr28Mo6 (ASTM F75 and F799-11) alloys are most widely used. Co alloys have 
excellent rigidity, low abrasion and fretting compared to Ti alloys (Revell,P. 2008).Their 
problems are similar to those associated with SS: the release of metal ions and high elastic 
modulus.
2.1.2.5 Tantalum-based materials 
Tantalum, marketed as Trabecular Metal, is expensive but bone-compatible biometal 
and has found use in trabecular implants and as an osseointegrating metallic cup shell, 
which can be utilized as a coating only on TiAl6V4 or carbon scaffolds. With excellent 
mechanical properties and bone fixation, tantalum has been shown to be nearly inert 
(Black,J. 1994). In the case of marked bone loss, tantalum has been used to supplement 
fixation in total knee arthroplasty (TKA) and THA (Meneghini,RM, et al. 2008, Rose,PS, 
et al. 2006).
2.1.3 Polymers
2.1.3.1 General properties of polymers 
In polymers, which represent the largest class of biomaterials, small molecular size 
monomers are usually linked to form high molecular weight compounds. Polymers may 
be derived originally from natural sources or organic synthetic processes. 
Most important mechanical properties of orthopedic polymers are yield stress and 
creep resistance (Hallab,N and Jacobs,J. 2013). They are used commonly as articular 
bearing surfaces or/and as an interposition cementing material between the implant surface 
and bone. Synthetic polymers have been widely used for hip and knee implants for 
decades, PMMA was introduced as a bone cement in 1958, and UHMWPE has been used 
in implant cups since 1962 (Kaivosoja,E, et al. 2012a). Additionally, polyaromatic 
polymers such as poly (aryl-ether-ether-ketone) (PEEK) have been recently discussed 
regarding isoelastic hip stems because of their useful properties like stiffness comparable 
to the bone (Kaivosoja,E, et al. 2012a). 
2.1.3.2 Polyethylene
Polyethylene (PE) is used as tubing for drains and catheters and in orthopedic medicine 
in ultrahigh molecular weight form as the acetabular component in artificial hips and other 
prosthetic joints. Beneficial properties of PE include toughness, wear resistance, and 
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biocompatibility. Radiation sterilization may enhance the strength of PE when done in the 
inert atmosphere. 
In UHMWPE, the increased crystallinity is due to better packing of linear chains, 
which gives improved mechanical properties. This is beneficial even though both ductility 
and fracture toughness decrease. The major downside to the use of UHMWPE with 
metallic heads relates to wear particle generation that in turn causes chronic inflammatory 
response mediated by macrophages. This response causes the release of lytic enzymes, 
bone resorbing mediators, and pro-inflammatory cytokines what leads to osteolysis in 
periprosthetic bone, fixation failure and aseptic loosening of the implant (Maloney,WJ, et 
al. 1990, Vernon-Roberts,B and Freeman,M. 1977, Willert,HG and Semlitsch,M. 1977). 
Cross-linking of polyethylene decreases abrasive, and adhesive wear rates and thermal 
treatments increase the oxidative stability of UHMWPE (Dorr,LD, et al. 2005, 
Kaivosoja,E, et al. 2012a). While the data on the clinical performance of highly cross-
linked polyethylene (HXLPE) is still limited and controversial, it has gained interest due 
to its ability to reduce polyethylene wear in TKA and THA (Affatato,S. 2012). 
2.1.3.3 Poly (methyl methacrylate) (PMMA) 
PMMA was introduced as orthopedic material in 1947 by the Judet brothers, and the 
first prosthesis was made entirely of PMMA (Judet,J. 1947). These first implants broke 
frequently, and their use was abandoned. 
PMMA is a hydrophobic, hard, rigid and biostable polymer. This amorphous material 
allows light transmittance and is used nowadays in acrylic bone cement as a filler material 
or for implant fixation. PMMA has also been utilized as dental filling material and in 
ophthalmology in intraocular lenses and hard contact lenses (Heath,D and Cooper,S. 
2013). 
2.1.4 Ceramics
2.1.4.1 General properties of ceramics 
The first ceramic material used in THA was alumina (Al2O3) in 1970 (Boutin,P. 1972). 
Nowadays ceramics are used in joint replacements as bearing surfaces or as coatings to 
improve bone bonding. Ceramics are the most biocompatible materials for bone repair and 
bone substitute applications due to their excellent inertness. As hard and wear-resistant 
materials, inert oxide ceramics minimize particle-induced osteolysis (Kumar,N, et al. 
2014). Ceramic-on-ceramic (CoC) bearings have low wear rate, are biocompatible and 
rarely cause allergic reactions compared to metallic prostheses (Wang,A, et al. 2003). 
Biocompatibility of ceramics comes from ionic bonding and chemical stability. As 
ceramics are harder than metals and have low wear rates, the CoC bearing couple is a 
desirable alternative. This bearing couple has a lower coefficient of friction and higher 
survivorship favoring its use with young and active individuals according to clinical 
studies (Murphy,SB, et al. 2006).
Nevertheless, reports have been made about weak fracture toughness and low bending 
strength regarding the use of ceramics in joint replacements (Boutin,P, et al. 1988, 
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Habermann,B, et al. 2006, Piconi,C and Maccauro,G. 1999). Problems with ceramics are 
often related to the ceramic bone interface and the insufficient osseous integration of 
ceramic materials (Hannouche,D, et al. 2005). 
With the development of materials science, the wear rates of the new composite 
ceramic bearings are markedly lower than those of older alumina bearings (D’Antonio,JA 
and Sutton,K. 2009, Tateiwa,T, et al. 2008). The popularity of ceramic bearings has 
increased widely due to these lower wear rates and steadily decreasing rates of fracture 
(nowadays 1 in 2000 over ten years) (Murphy,SB, et al. 2006). Particularly thick DLC 
coatings made with the FPAD method demand attention regarding orthopedic load-
bearing applications. The DLC and the DLC-p-h coatings were investigated in this thesis 
for their ability to resist bacterial adhesion and biofilm formation.
2.1.4.2 Diamond-like carbon and diamond-like carbon polymer hybrid coatings
Diamond is a crystalline solid carbon (C) allotrope with properties unrivaled by any 
other known material. Due to its high atom number density and the strong covalent 
bonding, it is the hardest of materials and the least compressible substance known. In 
diamond, carbon atoms are bonded with covalent bonds in a certain order. A neutral single 
C atom has six electrons surrounding the C atom nuclei, out of which four can create 
chemical bonds with C and other elements. Electron orbitals arrangement in the ground 
state of C-atom is marked as 1s22s22p2 configuration. C can form tetrahedral (sp3), trigonal 
(sp2) and linear (sp1) bond coordinations (Pierson,H. 1993), where the four (2s2 and 2p2)
electrons are converted into one out of these three basic hybridization configurations 
(Figure 1.) (Pierson,H. 1993).
Figure 1. The carbon atom has three hybridization configurations, three possible 
electron arrangements in the bonding process with C and other atoms. In sp1-
????????????????????????????????????????????????????????????-????????????????????????-bond 
directed along the ±x-????? ???? ???? ?????? ???????? ?????????? ????? ??????? ?-bonds 
(polymers). Sp2-configuration denotes that carbon forms stable allotrope graphite, where 
???????-????????????????????????????????????????????????????????-bond is perpendicular to 
the plane. In sp3- configuration diamond is formed, and in this allotrope, four strong 
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???????????? ?-bonds with 109-degree angles give the diamond its unique physical 
properties. Modified from: Soininen A. Studies of diamond-like carbon and diamond-like 
carbon polymer hybrid coatings deposited with filtered pulsed arc discharge method for 
biomedical applications. Unigrafia, Helsinki 2015, ISBN: 978-952-9657-78-0.
DLC was produced first time in 1969 by Aisenberg and Chabot (Aisenberg,S and 
Chabot,R. 1971). It has properties of both graphite and diamond, which is seen in a mixture 
of sp2 and sp3 C bonds and C existing in an amorphous phase. DLC is a general term that 
describes amorphous carbon coatings with "diamond-like" properties, which have any 
fraction of diamond sp3-bonds and varying hydrogen content in the film. Regarding sp3
diamond bond content in the coatings, the term tetrahedral amorphous carbon (ta-C) refers 
to coatings where sp3 diamond bond fraction exceeds 70%. When referred to hydrogenated 
coatings, hydrogenated ta-C (ta-C: H) can be used. In the case of a low sp3 fraction, 
amorphous carbon (a-C) and hydrogenated amorphous carbon (a-C: H) are the preferred 
terms respectively (Lifshitz,Y. 1999, McKenzie,DR. 1996). In this thesis, the DLC is used 
to denote only ta-C with a high fraction of sp3 diamond bonds (>80%) and no hydrogen 
contained unless otherwise noted. The term DLC polymer hybrid (DLC-p-h) similarly 
refers to a high fraction of sp3 diamond bonds in these novel hybrid materials (Anttila,A, 
et al. 2003).
The Diamond Group at the Orton Research Institute has studied DLC coatings since 
the mid-80s, and they can produce high-quality, well adherent and extremely thick DLC 
coatings (sp3 diamond bonds >80%, thickness >200μm) (Alakoski,E, et al. 2003, 
Anttila,A, et al. 1999). Superior adhesion of the coatings produced by The Diamond Group 
is due to the in-house developed Filtered Pulsed Arc Discharge (FPAD) method 
(Anttila,A. 1989) which is also used by the research group of Professor Reijo Lappalainen 
at the University of Eastern Finland. Recently, the main focus of the work done by The 
Diamond Group has been in the investigation of DLC coating for industrial and medical 
applications. Especially, they have assessed the wear reduction capabilities of DLC coated 
surfaces in high load-bearing applications such as in THA and hip resurfacing implants 
(Juvonen T,S, A., et al. Submitted 2015, Lappalainen,R, et al. 2003).
The DLC coatings produced by The Diamond Group and Prof. Lappalainen´s group 
have been tested in hip simulator studies. In the presence of bovine serum, the wear 
resistance of hip implants was improved by a factor of 106, when they were coated with 
thick (>10 μm) DLC, and compared to the wear resistance of traditionally used materials 
(Lappalainen,R, et al. 2003). Additionally, the corrosion of CoCrMo alloy was reduced by 
a factor of 105 in accelerated chemical corrosion studies when it was coated with 1-μm-
thick DLC (Anttila,A, et al. 1999, Lappalainen,R, et al. 2003, Tiainen,V. 2001). These 
results seem promising considering the problems such as the ion release with the MoM 
prostheses and the high wear rate of the metal-on-polyethylene (MoP) couple. 
Commercially available DLC coated cardiovascular implants such as artificial heart 
valves, blood pumps, and stents exist (Alakoski,E, et al. 2008, Donnet,C and Erdemir,A. 
2008, Roy,RK and Lee,KR. 2007), and DLC electrodes are used in biosensors (Freitas,R. 
2003). The DLC has been tested successfully as a coating for urinary tract catheters, 
guidewires, implants in the oral cavity, contact lenses and orthodontic archwires 
(Donnet,C and Erdemir,A. 2008, Elinson,VM, et al. 1999, Olborska,A, et al. 1994, 
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Webster,J. 2006). Researchers have also been investigating diamond coatings on drug 
delivery/sensing devices (Peiner,E, et al. 2007) and bone screws (Koistinen,A, et al. 2005)
and work on new future applications of diamond coatings continues vigorously.
In orthopedical load-bearing prosthesis field, so far no commercially successful 
applications exist. Several articles present DLC coatings as potential alternatives, but at 
the same time further testing is suggested (Alakoski,E, et al. 2008, Cui,FZ and Li,DJ. 
2000, Dearnaley,G and Arps,JH. 2005, Grill,A. 2003, Hauert,R. 2003, Hauert,R, et al. 
2013, Love,CA, et al. 2013, Roy,RK and Lee,KR. 2007).
When DLC is used as an implant coating in load-bearing applications, the importance 
of the adhesion of the films to the substrate comes into question. The coating has to be 
hard and thick to withstand high mechanical stresses, as in artificial hip and knee joints, 
when the peak loads are high (more than three times the body weight) (Paul,JP. 1966).  
Normally, high internal stresses in thick DLC coatings lead to delamination of the coating 
on hard materials. In the prevention of the delamination and loosening of the films from 
the substrate, the adhesive forces need to overcome the internal stresses in the films. 
Delamination of the coating occurs when the internal forces (increased with the thickness 
and sp3-fraction of the coating) exceed the adhesive forces. Especially with high-quality 
ta-C films, the internal compressive stress can be extremely high (Chhowalla,M. 2001, 
Robertson,J. 1998). Earlier, it has been thought that high-quality ta-C could not be 
deposited much thicker than 100 nm without increasing the risk of coating delamination 
from the substrate surface (Anttila,A, et al. 1997, Chhowalla,M. 2001).  
The Diamond Group have been able to deposit thick (>200 μm) high-quality DLC 
films with a proper selection of substrate materials combined with the production of an 
adequate intermixing layer with high energy carbon ions (Anttila,A, et al. 1999). Essential 
for the adhesion of the DLC coating to the substrate is the substrate materials ability to 
form carbides at the material coating interface. It has been shown that the carbide 
formation in the substrate leads to excellent adhesion of the DLC coatings (Anttila,A, et 
al. 1995, Anttila,A, et al. 1997, Tiainen,V. 2001, Utsumi,T, et al. 2007). The hardness of 
the substrate is another essential factor for proper adhesion of the DLC coatings, and the 
critical hardness limit has been shown to be HV 3 Gpa (Anttila,A, et al. 1997). Below this 
limit, high-quality DLC coatings at least up to 200 μm in thickness can be produced 
(Anttila,A, et al. 1999). Above the critical hardness value, the maximum thickness of the 
highest quality coatings is approximately 500 nm (Alakoski,E, et al. 2003).
The common issues of implant corrosion and wear of the THA could be minimized 
and delamination prevented with high quality and well adherent DLC coatings. Optimally, 
DLC could be used on both articulating surfaces, as Alakoski et al. suggest in the article 
which evaluates the use of DLC in load-bearing applications (Alakoski,E, et al. 2008).
Studies done by The Diamond Group have even led to the discovery of an entirely 
new group of materials, diamond-like carbon polymer hybrids (DLC-p-h). The FPAD 
system was modified to produce two novel hybrid coatings, DLC polytetrafluoroethylene 
hybrid (DLC-PTFE-h) and DLC polydimethylsiloxane hybrid (DLC-PDMS-h), where 
useful properties of DLC and chosen polymers could be combined (Anttila,A, et al. 1999). 
The Diamond group and the group of Prof. Lappalainen (in collaboration with other 
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research groups) have published nine articles where these novel coatings have been 
described and investigated (including articles II and III of this thesis) (Anttila,A, et al. 
2003, Calzado-Martin,A, et al. 2010, Huikko,K, et al. 2003, Kinnari,TJ, et al. 2008, 
Kiuru,M and Alakoski,E. 2004, Lappalainen,R, et al. 2003, Soininen,A, et al. 2014). The 
novel DLC-p-h coatings are anti-soiling with hydrophobic and oleophobic properties and 
have a high hardness (Lappalainen,R, et al. 2003). The polymer used and its amount in the 
resulting DLC hybrid coating determine the final properties of the coating. For hybrids 
mentioned above, PTFE and PDMS polymers were chosen because they are well known 
for their non-stick and anti-soiling properties. 
2.1.5 Biomaterial surface properties 
Implant surface characteristics affect bacterial adhesion and biofilm formation in a 
complex way. Despite a vast amount of research, much is still unknown how these surface 
properties influence the outcome of the events. Biomaterial surface factors are 
interconnected, and many chemical, physiological, physical and biochemical mechanisms 
are involved. As an example, changing surface chemistry directly also affects the surface 
charge, zeta-potential and surface energy of the surface. Even the initial protein adsorption 
is hard to predict due to different affinities and conformational states of the proteins, which 
material surfaces dictate. Additionally, not only non-specific physical interactions but also 
specific ligand-receptor mechanisms play a role in bacterial adhesion and biofilm 
formation.
2.1.5.1 Chemical composition
Biomaterial surface chemistry affects bacterial behavior in vivo through protein 
adsorption. The type of bonds formed between the material surfaces, proteins, and other 
solutes is regulated via material surface chemical composition, and the material surface 
dictates both the orientation and conformation of the adsorbed molecules. Therefore, the 
binding sites available for bacterial and human cellular adhesion are altered through 
changes in protein structure, which leads to the evolution in human and bacterial cellular 
binding to the substrate material (Kaivosoja,E, et al. 2012b). Depending on material 
hydrophobicity and charge, materials with different functional groups alter bacterial 
adhesion.
2.1.5.2 Surface topography 
Surface topography can refer to a surface texture with certain dimensional 
configurations. Surface topography also describes surface roughness, which is quantified 
by the vertical deviations of a real surface from its ideal form as a 2-dimensional 
parameter. Many different roughness parameters exist, and the arithmetic mean deviation 
of the surface (Ra) is the most common. It does not represent the morphological 
configurations of the surface. Surface configuration is a morphological description of the 
pattern of a material surface, and it is a three-dimensional parameter. Monofilament 
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surface, a braided surface, and a porous surface are examples of particular surface 
configurations (An,YH and Friedman,RJ. 1998).
Multiple studies have been made in the attempt to explain the relation between 
bacterial adhesion and surface topography and roughness, but the exact mechanisms 
remain largely unknown. This is mainly due to limitations in the characterization of 
substratum roughness and topography properties and complexity of the bacterial surface 
structures of a given species. Bacterial species, strain type, and bacterial size all influence 
surface roughness effect. 
There have been many reports linking material surface nano-topography with the risk 
of infection (Crawford,RJ, et al. 2012, Truong,VK, et al. 2015). Despite this, no standard 
protocols exist for examination of random surface features on implant materials related to 
bacterial adhesion. Much work has been done regarding the interaction of eukaryotic cells 
and implant surfaces, but studies evaluating the connection between surface nano-
topography and bacterial adhesion are lacking. Crawford RJ has recently proposed a set 
of topographical parameters for surface roughness characterization in bacterial adhesion 
studies (Crawford,RJ, et al. 2012). 
At the microscale, an optimal feature size may exist due to the limited capability of 
bacteria to deform. Extracellular structures of the cell membrane like flagella and fimbriae 
may have a role in bacterial responses to smaller topographical features (Anselme,K, et 
al. 2010). Finally, one has to consider that changes in surface roughnesses are related to 
changes in wettability and surface free energy (SFE) properties of a surface which make 
interpretation of bacterial interaction with surfaces complicated (Das,K, et al. 2009, 
Khang,D, et al. 2008, Ponsonnet,L, et al. 2003).
Arithmetic mean deviation of the surface (Ra):
Ra =
?
?? ? |?(?)|
??
? ?? (1)
Z (x) is the profile from a midline and lr is the sampling length over which the surface 
profile has been measured.
Material surface micro-and nano environment related to bacterial adhesion and biofilm 
formation is critical in modern implantology. Despite intense research in the area, little is 
understood of bacterial behavior on surfaces with defined textures. Differences in bacterial 
species, substrate material, feature aspect-ratio and geometry cause difficulties in 
interpreting results. The three-dimensional surface topography has been thought to have a 
significant influence on cell behavior on surfaces (Jager,M, et al. 2007, Martinez,E, et al. 
2009). There has been an understanding of specific "contact guidance" related to bone cell 
alignment along defined substrate morphologies (Charest,JL, et al. 2004, Hamilton,DW, 
et al. 2006). Recent study reports controlled bacterial mechanic-selective adhesion and 
inhibition of biofilm growth with the combination of nanoarray-induced bacterial 
patterning and modulation of the effective stiffness of the nanoarray (Epstein,AK, et al. 
2011).
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    2.1.5.3 Surface energy 
Wetting is defined as the ability of a liquid to maintain contact with a solid surface. 
Cohesive forces cause the drop to avoid contact between the liquid and surface and to ball 
up, whereas adhesive forces between a liquid and solid enable a liquid drop to spread 
across the surface. Force balance between these adhesive and cohesive forces determines 
the wetting property of the surface. The contact angle is an inverse measure of wettability, 
and it can be defined as the angle that forms when a liquid/vapor interface meets the solid 
surface. Wettable surfaces are called hydrophilic when water spreads on the surface, 
whereas non-wettable surfaces are called hydrophobic when a water droplet forms on the 
surface. Contact angles less than 65 usually describe wettable and hydrophilic properties 
(high surface energy), and contact angles greater than 65 present hydrophobicity and less 
tendency to wetting (low surface energy) (Vogler,EA. 1998). The solid surface wettability 
is influenced by the surface structure and the surface chemistry. Modifications in the 
surface roughness cause changes in the wettability characteristics of the surface.  
Patterning increases hydrophobicity in hydrophobic materials and hydrophilicity while in 
hydrophilic materials.
The surface energy of a homogeneous substance describes the energy required to form 
a unit area of new surface at the interface. The difference in the tendency of each phase to 
attract its molecules results in this free energy of the surfaces at an interface (Kaivosoja,E, 
et al. 2012b). The surface energy of the material is directly related to its wettability 
properties, which are commonly described by contact angle measurements. Surface energy 
also depends on chemical composition, crystallographic orientation, and roughness. The 
interfacial energies (solid-vapor interfacial energy  ???, solid-liquid interfacial energy ???, 
and the liquid-vapor interfacial energy ???) are derived from Young`s equation (Young,T. 
1805)???????????????????????????????????????????
??? = ???  +  ??? cos? (2)
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Figure 2. The contact angle and Young’s equation used to calculate the interfacial 
energies.
By using different polar and nonpolar liquids whose surface tensions are known in the 
contact angle measurements, it is possible to calculate a material’s surface free energy 
(SFE) and its components. Hydrogen bonding, dipole-dipole, dipole-induced dipole, and 
other site-specific interactions are described by the polar component of the material SFE. 
Van der Waals and other non-site specific interactions between solid surface and a liquid 
are related to the dispersive component of the material SFE.
2.1.5.4 Zeta potential 
???? ????? ?????????? ??-potential) describes the potential difference across phase 
boundaries between solids and liquids. An electric double-layer is formed when a solid 
surface is in contact with a fluid and surface charges accumulate. The zeta potential, or 
electrokinetic potential, is used to quantitate the magnitude of the electrical charge at the 
double layer. Near the solid-liquid interface, the charge carriers are fixed in the stationary 
layer, whereas, in the liquid phase, the charge carriers are at greater distances and they are 
mobile (mobile layer). These layers are separated by a plane of shear and the potential at 
this interface between immobile and mobile layers is referred to as the zeta potential. It is 
a measure of charges attracted by the material surface suspended in a liquid.
Zeta potential is one of the properties that may have a significant role in bacterial 
adhesion/biofilm formation on the surface. The presence of polyelectrolytes such as 
proteins and glycosaminoglycans in the dispersion fluid influence the zeta potential.
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Figure 3. A schematic presentation of the electrostatic double layer and the charge 
distribution. The zeta potential refers to the potential decay at the shear plane, between 
stationary and mobile layers.
2.1.6 Debris generation and ion release
Regarding implant performance in clinical use, implant material degradation and 
debris formation by wear and corrosion and host response to this debris are important. 
Wear describes the loss of material in particulate form as a consequence of relative motion 
between two surfaces. With corrosion, material gradually destructs by chemical reaction 
with the environment. This way metal is converted to its more stable oxide. The 
degradation products (debris) of all orthopedic implants can be wear particles, colloidal 
nanometer size complexes bound by protein, soluble debris (metal ions), and inorganic 
metal salts/oxides or in an organic storage form such as hemosiderin (Hallab,N and 
Jacobs,J. 2013).
Primary local effect of implant debris by wear and corrosion is osteolysis around the 
implant. The exact mechanism by how sterile, relatively inert implant debris causes 
inflammation is unclear, and considerable efforts are on the way in research. When remote 
and systemic effects of debris are considered, many unsolved issues remain. While wear 
and electrochemical corrosion degrade useful properties of materials, the resulting debris 
has been associated with adverse effects in human body. Remote and local adverse effects 
and host response to debris formed by wear or electrochemical corrosion might be 
determined by host factors and the amount, quality, and type of debris created (chemical 
form). Additionally, different orthopedic materials and couples produce different kinds 
and quantities of debris (Hallab,N and Jacobs,J. 2013). 
Particulate wear debris accumulation in the tissues is followed by inflammatory 
reaction and local bone loss (aseptic osteolysis) which can eventually lead to implant 
failure. This particulate debris may also be phagocytosed within macrophages and migrate 
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via lymphatics to distant organs and lymph nodes. It may cause granulomatous lesions, 
lymphadenopathy, inflammation, and fibrosis. With wear rates of more than 0.1 mm/year, 
osteolysis occurs more commonly, and it is uncommon with wear rate less than 0.05 
mm/year (Dumbleton,JH, et al. 2002). MoP couples generally produce more wear than 
hard-on-hard material couples such as metal-on-metal articulations. The macrophage 
reactions to debris have been seen to determine debris-induced inflammation that is the 
most leading cause of implant loosening over time (Hallab,N and Jacobs,J. 2013). In long-
term use, aseptic osteolysis accounts for over 75% of implant failures in TJA (Holt,G, et 
al. 2007). 
During implantation or wear or upon chemical interaction with a biologic 
environment, metal ions can be released through corrosion. On the infected substratum, 
iron may accumulate and supply bacteria and inhibit macrophage function. Iron has been 
associated with virulence of S.aureus and S.epidermidis (Gristina,AG. 1987). Trace ions 
(e.g. Mg 2+, Ca 2+) in microzones present on implant surface may enhance cell-to-cell 
and cell-to-surface binding in biofilms and increase resistance to external threats 
(Dankert,J, et al. 1986). 
Metal ions released from the implant may bind to specific proteins and disseminate via 
lymphatics or circulation and accumulate in organs such as spleen or liver. There have 
been reports about the elevated serum and urine levels of some metal ions after THA 
operation. Implant alloys in modern orthopedics include elements potentially toxic to the 
human body: titanium, aluminum, vanadium, cobalt, chromium and nickel. In soluble 
form and excessive amounts, adverse effects may follow. There have also been reports of 
immunologic type responses temporally associated with implanted metal components. 
Metal hypersensitivity is common and has been linked to ingestion or dermal contacts with 
metals. Dermal hypersensitivity manifests as skin hives, eczema, redness, and itching. 
Metal toxicity of debris may have several patterns: it may alter metabolic events, 
change host/parasite interactions, act as haptens and activate immunological responses and 
be anti-chemotactic and finally cause chemical carcinogenesis. Nevertheless, at this time 
any metal release related to metabolic, bacteriologic, immunologic or carcinogenic 
toxicity is still without confirmation because cause and effect relation has not been well-
established in human subjects (Hallab,N and Jacobs,J. 2013). 
2.2 Protein adsorption and conditioning film 
In an aqueous environment, as in human body, molecules, inorganic or organic are 
carried to the surface either by diffusion or turbulent flow (Palmer,J, et al. 2007). The 
accumulation of molecules at the solid-liquid interface on surfaces is called a conditioning 
film. Whenever an implant is inserted into the human body, and it comes into contact with 
tissue fluids or blood; first the surfaces are covered by water molecules (in nanoseconds) 
(Roach,P, et al. 2007). The organization of water molecules at the material-liquid interface 
depends on physicochemical properties of the surface. Water molecules are more 
organized at hydrophilic surfaces, which have strong tendency to bind water. On 
hydrophobic surfaces water molecules are less organized concerning hydrogen bonding; 
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thus, hydrophobic surfaces have a weak tendency to bind water. After the formation of the 
hydration shell, an adsorbed water layer, hydrated ions get involved according to 
properties of the surface. Glycoproteinaceous conditioning film is formed as the implant 
surface is immediately (in seconds) coated with plasma proteins, platelets and various 
extracellular matrix molecules such as fibronectin, collagen, and fibrinogen derived from 
tissue fluids, blood, and ECM. Bacterial and tissue cell adhesion is subsequently possible 
via this conditioning film (Dankert,J, et al. 1986). 
In vivo, the conditioning film forms before microorganisms or tissue cells adhere 
because adsorption of microbes and tissue cells to a substratum proceed relatively slow 
compared to that of molecules (Escher,A and Characklis,W. 1990, Gristina,AG. 1987). 
The affinities of the proteins and surfaces, as well as the mass concentration of the proteins 
in the bulk phase, decide the outcome of the competitive adsorption of proteins to the 
surface. This explains why the concentration of low-affinity protein albumin, adsorbed 
from plasma on the surface, is about the same as that for fibrinogen. The concentration of 
albumin in plasma is much higher than that of high-affinity fibrinogen. Physicochemical 
characteristics of the surface, especially wettability (hydrophilicity or hydrophobicity), 
play a role in this process (Wilson,CJ, et al. 2005). Proteins might also change their 
conformation (folding of proteins) when adhering to the surface and this way their 
biological functions may be altered. This relates to protein stability, which affects protein 
adsorption. So-called soft proteins have a low internal stability and unfold more smoothly 
during initial adhesion. Hard proteins have high internal stability and unfold less easily.
Thermodynamically labile proteins are more adsorptive than stable proteins due to their 
unfolding in response to denaturing conditions more easily. Generally, on hydrophobic 
surfaces, protein adsorption is greater compared to adsorption on hydrophilic surfaces 
(Wilson,CJ, et al. 2005). When adhering to the hydrophilic surface, proteins retain their 
natural conformation better.
The physicochemical properties of the surface (surface free energy, hydrophobicity, 
and electrostatic charges) are altered then by the conditioning film. The protein layer has 
a major role both in bacterial and tissue adhesion (Dickson,JS and Koohmaraie,M. 1989)
because the adhering bacteria and tissue cells come into contact first with a conditioning 
film and other cells and their products rather than a bare substratum surface.
2.3 Implant infections
2.3.1 Overview 
Surgical operations are always associated with a particular risk of complications. With 
arthroplasty, possible complications and reasons for revision surgery due to the failure of 
the primary implant include infection, poor biocompatibility, dislocation, instability, 
fracture, poor surgical technique and wear/corrosion. Often the implant failure is related 
to the mechanical properties of the implant. Such conditions include wear/corrosion, low 
fracture toughness/low fatigue strength, and stress shielding, where there is a mismatch in 
elastic modulus of implant material compared to that of bone (Geetha,M, et al. 2009). 
According to Wolff´s law (Wolff,J. 1892), when rigidly fixed stiff femoral components 
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shield the bone from stress, the resorption of proximal femoral bone may increase in lack 
of loading that would strengthen the bone. 
Wear and corrosion induced particle debris can predispose the periprosthetic tissues to 
chronic inflammation and foreign body reaction, which ultimately may lead to osteolysis 
and pathologic fracture. Other cause of aseptic loosening of the implant can be poor 
integration between implant surface with bone and surrounding tissues due to 
micromotions in the case of inefficient primary stability of the implant, which may lead 
to fibrous encapsulation.
Prosthetic joint infections (PJIs) occur more rarely than aseptic failures, but the 
consequences are much more dramatic due to the high morbidity and health-care costs 
associated with the complication (Waldwogel,F and Bisno,A. 2000). Due to better 
detection methods in diagnostics, increasing number of implanted prostheses amongst 
seniors and younger people involved in sports accidents, the incidence of PJIs is expected 
to rise. Additionally, with longer expected residency time of prostheses, infections become 
even more widespread. 
The risk of an implant infection is dependent on the type of the implant and location 
in the human body and is increased with reimplantation (revision). In Mayo Clinic survey 
between 1969 and 1996, the prevalence of PJIs for primary THA or TKA was 1.3% or 
2.0% respectively. For revision THA or TKA, the prevalence was 3.2% or 5.6% 
(Hanssen,A and Rand,J. 1999). Among orthopedic devices the infection rate with primary 
hip replacement patients during the first two years after initial implantation is usually less 
than 1% and in those with knee replacement less than 2%. After revision surgery, the 
infection rates are much higher (5-40%) than after primary replacement (Trampuz,A and 
Widmer,AF. 2006). In the Nordic Arthroplasty Register Association (NARA) database, 
432 168 primary THAs were registered between 1995 and 2009 of which 2778 (0.6%) 
were revised due to infection (Dale,H, et al. 2012). In 2013, of 1777 registered THA 
revisions in Finland, 10.8% were performed because of an infection (Rainio J,PA. 2014). 
About 45% of all nosocomial infections are implant-related (Schierholz,JM and Beuth,J. 
2001) and the annual costs for approximately 2 million nosocomial infections were near 
$11 billion in the United States in 2001 (Schierholz,JM and Beuth,J. 2001). 
The focus in pathogenic agents in this thesis is mainly on two staphylococcal species, 
S.aureus, and S.epidermidis, which are most often associated microorganisms with 
orthopedic implant infections. Approximately two-thirds of orthopedic implant infections 
are caused by either S.aureus or S.epidermidis (Campoccia,D, et al. 2006). Among the 
PJIs, 20-40% is hematogenous, and the rest are from direct contaminations. Most often 
PJIs are derived from contamination of the surgical wound (Dellinger,E, et al. 2007)
The detailed clinical diagnostic and treatment processes of PJIs are out of the scope of 
this thesis. However, for successful treatment of implant infections, it is often necessary 
to remove the implant and administer antibiotics for a longer period before reimplantation 
to avoid recurrent infections at the same site. Even low bacterial counts can contaminate 
the implant or surgical wound, due to the presence of abiotic foreign bodies and impaired 
local host responses. Therefore, it is impossible to insert the implant under 100% sterile 
conditions even with modern operating rooms, where strict procedures are followed by 
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experienced operating teams. This means that contamination of an implant might be 
almost unavoidable, and it is indeed the consensus today that the incidence of microbial 
contamination of the implants is considerably underestimated. 
As active players in the host defense settings, antimicrobial peptides (AMPs) are 
human body´s natural antibiotics. Their presence and production have been associated 
with several inflammatory and infectious processes, including septic joint implant 
loosening. In recent years, their functions have been reported to link innate and adaptive 
???????????????????????? ????????? ??? ???????-defensin-3 (hBD-3), which belongs to the 
largest AMP family of defensins. In literature, hBD-3 has been studied regarding its 
antimicrobial activity and possible utilization in diagnostics (Lee,JK, et al. 2013, Liu,GD, 
et al. 2014). 
2.3.2. Definition 
Deep joint implant-related infections are difficult to recognize especially when pain is 
the only notable symptom. The Musculoskeletal Infection Society (MSIS) has agreed on 
criteria (published in the November 2011 issue of the Journal of Clinical Orthopedics and 
Related Research (Parvizi,J, et al. 2011), which should be met for definite PJI diagnosis. 
The International Consensus Meeting (ICM) on PJI supported the MSIS definition of PJI 
in August 2013 and modified it by adding a minor criterion (leukocyte esterase test) and 
determining the threshold for lab results, Table 1,  (Parvizi,J, et al. 2013, Parvizi,J, et al. 
2014, Shahi,A and Parvizi,J. 2015).
The modified definition states that a definite PJI is present when following criteria are 
met:
Table 1. The definition of a prosthetic joint infection.(Parvizi,J, et al. 2014).
The definition is based on the demonstration of a causative microbe associated with 
clear signs of the host inflammatory response. In some low-grade infections, several of 
these criteria may not be routinely met despite the presence of PJI. 
A. There is a sinus tract communicating with the prosthesis, OR; 
B. A phenotypically identical pathogen is isolated by culture from 2 or 
more separate tissue or fluid samples obtained from the affected 
prosthetic joint, OR; 
C. When three of the following five criteria are present: 
1. Elevated serum erythrocyte sedimentation rate AND serum C-
reactive protein concentration 
2. Elevated synovial white blood cell count, OR ++ change on 
leukocyte esterase test strip 
3. Elevated synovial polymorphonuclear percentage 
4. Positive histological analysis of periprosthetic tissue 
5. A single positive culture 
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Another large international workgroup, the Infectious Diseases Society of America 
(IDSA), recently published also a consensus document regarding the standardization of 
the definition of PJI (Osmon,DR, et al. 2013). Considering the history and physical 
examination, according to IDSA, PJI should be suspected in patients with certain 
conditions. These conditions include a sinus tract or persistent wound drainage over a 
joint; acute onset of a painful prosthesis; or a chronically painful prosthesis at any time 
postoperatively. Particularly a chronically painful prosthesis postoperatively is alarming 
in the absence of a pain-free period in the first few years after implantation. Also, if a 
patient presents with a chronically painful prosthesis postoperatively with a history of 
wound-healing problems or a superficial wound infection, further evaluations are ordered 
(Osmon,DR, et al. 2013).
2.3.3 The staphylococci
    2.3.3.1 Overview 
Immobile, gram-positive staphylococci are 0.5-1.5 μm in diameter and are 
characterized by individual cocci forming grape-like clusters in more than one plane. 
Pathogenic staphylococci such as S.aureus can clot blood and produce coagulase 
(Kloos,WE and Musselwhite,MS. 1975) and are in this way often identified distinguishing 
them from coagulase-negative staphylococci (CoNS) like S.epidermidis, S. lugdunensis, 
and S.Saprophyticus. 
The staphylococci are often found in the normal flora of the human skin and mucous 
membranes. Staphylococcal cell wall consists mainly of peptidoglycan and phosphate-
containing polymers called teichoic acids. Through localization of metal ions and the 
activities of autolytic enzymes, a negative charge is created on the staphylococcal cell 
surface by these teichoic acids (Gross,M, et al. 2001). Additionally, the cell wall includes 
surface proteins called adhesins, exoproteins (exotoxins) and peptidoglycan hydrolases 
(autolysins). In S.aureus and S.epidermidis, teichoic acids and the surface protein 
autolysin have been associated with abiotic surface attachment (Gross,M, et al. 2001, 
Heilmann,C, et al. 1997). They probably act indirectly, through alteration of surface 
hydrophobicity (Joo,HS and Otto,M. 2012). 
Bacterial capsules and slime are both subclasses of extracellular polymeric substances 
(EPS) and are usually polysaccharides (An,YH and Friedman,RJ. 1998), which can bind 
to surfaces or surface adsorbates and may function in cell-to-cell aggregation. Bacterial 
capsules are separated from extracellular slime as a discrete covering layer with clear 
margin on the bacterial cells outside of the cell wall, and they can be found both in Gram-
negative and Gram-positive bacteria. Bacterial strains that do not produce slime have been 
shown to be less pathogenic (Davenport,DS, et al. 1986).
S.aureus and S.epidermidis adhere to cells, plasma and extracellular matrix (ECM) 
proteins such as fibronectin, fibrinogen, collagen, vitronectin and laminin (Foster,TJ and 
McDevitt,D. 1994) with microbial surface components recognizing adhesive matrix 
molecules (MSCRAMMs)- adhesins (Patti,JM, et al. 1994). This is significant especially 
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in wounds and foreign body infections. One single MSCRAMM can bind several ECM 
ligands while a microorganism can express several MSCRAMMs that bind into the same 
matrix molecule (McDevitt,D, et al. 1994). Some MSCRAMMs have been identified, such 
as fibronectin binding proteins, clumping factor binding proteins and collagen binding 
proteins (Herrmann,M, et al. 1988). It has been reported that polysaccharide intercellular 
adhesin (PIA) maintains connections between bacteria in biofilm and plays a vital role in 
biofilm formation (Mack,D, et al. 1996b). 
S.aureus and S.epidermidis cause most of the implant infections. Especially CoNS 
such as S.epidermidis, which mainly is associated with foreign body infections, are 
implicated. New causative agents resistant to antibiotics have evolved such as MRSA and 
vancomycin insensitive S.aures (VISA). Also, S.epidermidis has shown high resistance to 
antibiotics and nosocomial infections caused by S.epidermidis are often very hard to treat. 
The survival and growth of staphylococci are possible only with adaptation to 
environment. This adjustment is maintained by multiple mechanisms including bacterial 
adhesion, phenotype change, biofilm formation, changes in metabolic state of the bacteria, 
quorum sensing (communication and signaling between bacteria) and various virulence 
factors. The virulence factors of S. aureus and S.epidermidis include structures of the 
microbial cell, secreted products by the microbe and the genetics of antibiotic resistance. 
      2.3.3.2 Staphylococcus aureus
S.aureus often causes metal-biomaterial, bone-joint and soft-tissue infections (Barth,E, 
et al. 1989, Petty,W, et al. 1985). It is a virulent pathogen among immunocompromised 
and healthy individuals because it produces extracellular toxins (enterotoxin A-E, toxic 
shock syndrome toxin-1 (TSST-1)), extracellular proteases (metalloproteases, serine 
proteases V8 (SspA)), and exfoliative toxins (Projan,S and Novick,R. 1997).
S.aureus is present on the skin and in the nasopharynx of the human body and is the 
pathogen in many minor local infections of the skin, nose, urethra, vagina and 
gastrointestinal tract (Shulman,J and Nahmias,A. 1972). Surgical wound infections can be 
caused by S.aureus as well as more severe disease states such as endocarditis, 
osteomyelitis, toxic shock syndrome and even septicemia through lymphatic channels or 
blood. S.aureus causes characteristic local abscess lesions in the tissues underlying the 
skin (Elek,SD. 1956). 
Through plasmids and genetic spread resistance to antibiotics MRSA has evolved and 
is nowadays a common problem in the hospitals around the world, even though in Nordic 
countries it is still quite a rare pathogen. MRSA strains produce penicillin binding protein 
??????? ?????????????????????-lactam antibiotics in such a way that the cell wall of bacteria 
can be synthesized even in the presence of the antibiotic (Hiramatsu,K. 1995). 
Vancomycin glycopeptide has been the antibiotic drug of choice against MRSA infections. 
Nevertheless, since 1996 several VISA strains have been reported (Spagnolo,AM, et al. 
2014).
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2.3.3.3 Staphylococcus epidermidis
S.epidermidis is the most important CoNS species, covering 65-95% of all 
staphylococci in the skin and mucous membrane normal flora and is often causative agent 
in polymer-associated implant infections (von Eiff,C, et al. 2002). It is widely distributed 
in nose mucosa, perianal region, loins, armpits and between toes. S.epidermidis is one of 
the most often isolated microorganisms in hospitals and covers most implant infections 
caused by CoNS. It has been found to be more resistant to antibiotics than S.aureus 
(Johnson,AP, et al. 2003, Vuong,C and Otto,M. 2002). The rise of methicillin-resistant 
S.epidermidis (MRSE) (Tammelin,A, et al. 2000) and intermediate vancomycin resistance 
(Raad,I, et al. 1998) create difficulties in the eradication of these infections. 
As S.epidermidis and other CoNS excluding Staphylococcus saprophyticus are 
opportunistic bacteria, they do not cause infections in normal circumstances. Otto M 
termed S.epidermidis as "accidental pathogen" pointing out its nature as opportunistic 
microbe (Otto,M. 2009). Many virulence determinants of S.epidermidis are thought to 
have original functions in its commensal non-infectious lifestyle on the skin and the 
normal flora. Exposure to an immunocompromising agent such as a skin wound, implant 
or chronic disease is needed in case of "accidental" infection caused by this opportunistic 
microorganism. The frequency of possible contamination events and mechanisms affect 
more to the clinical importance of S.epidermidis infections than its non-infectious 
lifestyle. S.epidermidis possesses more determinants promoting persistence (such as 
immune evasion molecules), rather than those associated with aggressive anti-host attacks 
such as toxins (Otto,M. 2009), which clarifies the low virulence of S.epidermidis. 
S.epidermidis is less cytotoxic and virulent than S.aureus even though it produces 
extracellular toxins such as ?-toxin and proteases (von Eiff,C, et al. 2002). 
When S.epidermidis adheres to an implant surface, it starts to form a biofilm, which is 
characteristic for S.epidermidis. In the biofilm, bacterial cells are attached to each other 
with PIAs, which are essential for biofilm formation and host attack evasion (Mack,D, et 
al. 1996b, Vuong,C, et al. 2004b).
2.3.4 Bacterial adhesion
2.3.4.1 Definition and mechanisms        
Bacterial adhesion is defined as a process where bacteria adhere firmly to a biotic or 
abiotic surface by complete physicochemical interactions between them. Initial phase of 
reversible physical contact is followed by time-dependent phase of irreversible chemical 
and cellular adherence (An,YH and Friedman,RJ. 1998). Co-aggregation is a term that 
describes adhesion of planktonic bacteria to each other and co-adhesion means adhesion 
of planktonic single or co-aggregated microbes to surface-bound sessile microorganisms, 
sometimes called primary colonizers (Whittaker,CJ, et al. 1996). The sessile surface-
bound bacteria can stimulate adhesion of other, still suspended planktonic microbial cells. 
This can happen either by slowing them down while they are approaching the surface 
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(Busscher,HJ, et al. 1991, Dabros,T. 1989) or through strong attractive interactions as in 
co-adhesion (Bos,R, et al. 1995). 
As biological systems are diverse and bacterial adhesion is a highly complicated and 
multifactorial process, it is not completely understood even though various theories have 
been made to explain the phenomenon. The outcome of the process seems to be 
determined by physical and chemical interactions that are attractive or repulsive, 
depending on the interplay among the chemistries of the bacterial and substratum surfaces 
and the aqueous phase. Bacterial properties, environmental properties, and surface 
properties all contribute to the process. Cell surface proteins, polysaccharides, 
conditioning films on surfaces, and biological changes in adhering bacteria seem to affect 
bacterial adhesion in a way that prediction of the process is virtually impossible based 
only on the physicochemical models of the different theories (Katsikogianni,M and 
Missirlis,YF. 2004). Hence experiments in vitro and in vivo are needed.
2.3.4.2 Phase one: initial adhesion 
The reversible and initial non-specific phase of bacterial adhesion involves 
physicochemical forces. First, planktonic bacteria move to or are driven to a material 
surface by the effects of physical forces such as van der Waals attraction forces, 
gravitational forces (sedimentation), Brownian motion, the effect of electrostatic surface 
charge, hydrophobic interactions or a convective mass transport (Gottenbos,B, et al. 
2002). 
Concentration gradients of diffusible ("chemotaxis") or surface bound ("haptotaxis") 
chemical factors, chemoattractants (e.g. amino acids, sugars, oligopeptides) can direct 
movement of bacteria (diffusion), and specially chemotaxis can modulate bacterial growth 
on surfaces. Chemotaxis regulates cellular adhesion components and prepares cells for 
cell-cell and cell-surface interactions (Jenal,U. 2004). The intrinsic motility of a microbe 
has a role in the microbial movement as they can even actively move with surface-
associated appendages such as flagella. 
The physical interactions have been further classified as long-range interactions and 
short-range interactions (Gottenbos,B, et al. 2002, Katsikogianni,M and Missirlis,YF. 
2004). Bacteria are transported to the surface with nonspecific long-range interactions 
(distances > 50nm) which are a function of the distance and free energy (van der Waals 
forces, electrostatic interactions). Short-range interactions such as ionic and dipole 
interactions, chemical bonds (e.g. hydrogen bonds), and hydrophobic interactions become 
effective with closer contact to the surface (< 5 nm) (Mayer,C, et al. 1999), where specific 
adhesion receptors may facilitate strong adhesion. 
The initial early phase can be described as a reversible attachment while the late phase 
involves firmer adhesion with the surface through molecular reactions between bacterial 
surface structures and substratum surface.
2.3.4.3 Phase two: late adhesion 
Specific irreversible adhesion can be defined as the selective binding between bacterial 
adhesin (a specific molecular component on a bacterial surface) and substratum receptor 
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(a specific component on a material surface or tissue surface). This late adhesion is less 
affected by many common environmental factors such as electrolytes, pH, or temperature
(An,Y, et al. 2010). 
Specific adhesion of bacteria is believed to be important in the pathogenesis of 
prosthetic infections (Timmerman,CP, et al. 1991). Bacterial surface polymeric structures 
such as capsules, fimbriae or pili, and slime mediate this specific irreversible phase of 
bacterial adhesion (Dunne,WM,Jr. 2002). Their functional parts, adhesins, make specific 
and secure connections with the surface (especially when the substratum are host tissues) 
in this time-dependent phase that involves molecular and cellular interactions (Gotz,F. 
2002, Mack,D. 1999, O'Gara,JP and Humphreys,H. 2001). Bacterial fimbriae have been 
associated with virulence (Hacker,J. 1992). In addition to specific binding, they may also 
react nonspecifically with inorganic substratum elements by charged or hydrophobic 
interactions (Gristina,AG. 1987). 
MSCRAMMs are well-studied adhesins of staphylococci and some other bacteria. 
They play a major role in this irreversible adhesion and subsequent formation of multi-
layered bacterial biofilm. Along with intercellular adhesion, this especially involves 
binding to host tissues and conditioning film. 
2.3.4.4 Bacterial properties
Different bacterial strains and species adhere differently to substratum since they have 
different physicochemical characteristics. Physicochemical characteristics of bacteria 
depend on components and molecules (e.g. adhesins, different proteins, polysaccharides 
and ionic groups) of bacterial surface structures such as fimbriae, teichoic acids, capsule 
and cell wall. These characteristics are also affected by environment (e.g. growth medium, 
the ionic strength of the medium, other microorganisms, and surface material properties). 
Hydrophobicity has been thought to be a major factor in bacterial adhesion and refers 
to the organization of water molecules in the region near any surface in aqueous solution. 
Bacteria with hydrophobic properties prefer hydrophobic material surfaces, and the ones 
with hydrophilic characteristics prefer hydrophilic surfaces (Katsikogianni,M and 
Missirlis,YF. 2004), and hydrophobic bacteria adhere to a greater extent than hydrophilic 
bacteria (van Loosdrecht,MC, et al. 1987). 
Bacteria in aqueous suspension are always negatively charged due to the ionization of 
their surface groups (Hogt,AH, et al. 1985), and they have a net negative zeta-potential on 
their cell wall at neutral pH (Gilbert,P, et al. 1991). Growth medium, the pH and the ionic 
strength of the suspending buffer, bacterial age, and bacterial surface structure influence 
the surface charge of the bacteria which varies according to bacterial species (Dankert,J, 
et al. 1986). The charge on the bacterial cell surface often referred to as its zeta-potential 
or electrokinetic potential, is calculated from the mobility of the bacterial cell in the 
presence of an electrical field under defined salt concentration and pH.
In the case of multiple bacterial species or strains in the tissues or on the substratum, 
the severity of infections is increased (Merritt,K. 1988). The presence of pre-adhered 
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organisms has been shown to enhance biofilm mass and bacterial adherence in vivo and in 
vitro (Chang,CC and Merritt,K. 1991, Chang,CC and Merritt,K. 1994).
      2.3.4.5 Biomaterial properties 
Material surface characteristics such as chemical composition, surface charge, 
hydrophobicity, surface roughness and physical configuration influence bacterial 
adherence to a biomaterial surface. Biofilms and conditioning film alter material surface 
energy, empty binding sites, and hydrophobicity (Gristina,AG. 1987). It has been seen that 
in adhesion S.epidermidis prefers polymers and S.aureus metals (Gristina,A, et al. 1987). 
Material surface chemistry has an effect on bacterial adhesion due to different 
functional groups of materials which change material hydrophobicity and charge. This has 
been shown in work done by Tegouila and Cooper (Tegoulia,VA and Cooper,SL. 2002). 
S.aureus adhesion on self-assembled monolayers (SAMs) terminated with methyl, 
hydroxylic, carboxylic acid and tri (ethylene oxide) was investigated. The adhesion was 
lowest on ethylene oxide-bearing surfaces (EG3), followed by the hydroxyl surfaces, and 
higher on carboxylic-and methyl-terminated SAMs. Bacterial adhesion can be inhibited 
with surface chemistry modifications. Silver (Silver,S. 2003), DLC (Hauert,R. 2003) and 
plasma coatings (Whitehead,KA, et al. 2004) have been used to decrease the number of 
adherent bacteria on material surfaces. Peptide coatings (Harris,LG, et al. 2004) and 
nonsteroidal anti-inflammatory drug coatings (Baveja,JK, et al. 2004) also have been 
shown to hinder bacterial adhesion.
Surface roughness is commonly described as the arithmetic average roughness. Many 
groups have reported greater cell attachment on surfaces with high surface roughness and 
irregularities on surfaces, due maybe to increased surface area and the depressions in the 
roughened surfaces, which provide more sites for colonization (Baker,AS and 
Greenham,LW. 1988) and also protect from cleaning chemicals and fluid forces. 
Therefore, smoothening of the surface can reduce biofilm formation (Ionescu,A, et al. 
2012). A roughness level Ra equal to 0.2 μm was suggested to be the threshold value for 
maximum reduction of bacterial adhesion (Quirynen,M, et al. 1996). Nevertheless, a 
universally optimum roughness value has not been found that could reduce adhesion of all 
bacterial species (Renner,LD and Weibel,DB. 2011). The specific effects of surface 
roughness on bacterial adhesion and biofilm formation vary with the size and shape of 
bacterial cells and other environmental factors.
Physical surface configuration is a morphological description of the pattern of a 
material surface, such as a monofilament surface, a porous surface, or gridlike surface, 
and it is a 3-dimensional parameter routinely evaluated by scanning electron microscopy 
(An,YH and Friedman,RJ. 1998). Bacteria adhere more to porous, grooved and braided 
materials compared to flat ones, probably partially due to increased surface area (Bos,R, 
et al. 2000). Surface topography and irregularities around the critical size close to the 
diameter of the microbes may entrap bacteria and provide protection from fluid flow and 
increase the retention forces of adherent bacteria and biofilm on the surface. Grooves or 
scratches that are close to the bacterial size increase the contact area and binding, whereas 
grooves that are much larger than the bacterial size show binding potential of a flat surface. 
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Irregularities too small for the bacteria to fit into them reduce the contact area and binding 
(Edwards,KJ and Rutenberg,AD. 2001).
Biomaterial surface hydrophobicity and charge have been suggested to be important 
factors in bacterial adhesion. Metal surfaces have a high surface energy and are negatively 
charged and hydrophilic as seen from water contact angles. Polymers such as UHMWPE 
are less electrostatically charged, hydrophobic and have low surface energy. Bacteria 
adhere differently to materials with different hydrophobicities depending on the 
hydrophobicities of both bacteria and material surfaces. Hydrophobic material surfaces 
attract bacteria with hydrophobic surfaces, and hydrophilic material surfaces attract 
microbes with hydrophilic surfaces. 
The atomic structure of the surface presents energy profiles or available binding sites 
for bacteria. Most substrata have a negative charge, but it can vary depending on pH, 
inflammation and tissue damage caused by surgery, trauma, infection, and corrosion, 
which alter pH and charge. Usually, electrostatic interactions create repulsion between 
bacteria and substratum because surfaces of bacteria and material tend to both have a 
negative charge. Surface texture, manufacturing processes, trace chemicals and debris, 
and by ionic and glycoproteinaceous constituents from the host environment (conditioning 
film), binding sites are further modified regarding polymer and metal surfaces 
(Gristina,AG. 1987). 
Environmental conditions for opportunistic bacteria to start infections are established 
through substratum disruption by trauma, wear, corrosion, toxins, viral effects, bacterial 
mechanisms or biosystem chemical degradation. Implant materials are surrounded by an 
immuno-incompetent, fibro-inflammatory zone, where stimulation of cellular immune 
responses results in superoxide radical and cytokine-mediated tissue damage which further 
increases susceptibility to implant infection or aseptic loosening (Gristina,AG. 1987, 
Gristina,AG. 1994, Tang,L and Eaton,JW. 1995). Material mediated inflammatory 
processes may even cause degradation of the material itself (via oxidative products) and 
thus, increase susceptibility to infection (Tang,L and Eaton,JW. 1995).
2.3.4.6 Environmental properties 
Environmental factors such as temperature, time of exposure, bacterial concentration, 
the presence of antibiotics, chemical treatment and flow conditions affect bacterial 
adhesion. Flow conditions strongly influence the number of attached bacteria (Isberg,RR 
and Barnes,P. 2002), the biofilm structure and performance (Stoodley,P, et al. 1999). 
Higher shear rates result in greater detachment forces that decrease the number of attached 
bacteria and make the biofilm denser and thinner (Chang,HT, et al. 1991). 
In ligand/receptor-mediated specific bacterial adhesion, the number of bonds that can 
form will be a function of ligand and receptor densities (Hubble,J, et al. 1996, Mascari,L, 
et al. 2003). If each bond requires a specific force to break it, the number of bonds between 
a microbe and a surface determine the shear stress that the attached bacterium will be able 
to resist. An optimum flow rate for bacterial attachment has been found, describing the 
balance between the speed of the delivery and the force acting on attached bacterium 
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(Liu,Y and Tay,JH. 2002). For S.aureus, in the case of a higher number of receptors/cell, 
between shear rates 50-300 s-1, adhesion to collagen coated coverslips increases and then 
decreases for shear rates greater than 500 s-1 (Mohamed,N, et al. 2000). Thus, binding is 
increased, up to a certain shear rate (Mohamed,N, et al. 2000). Greater mass transport 
means that more bacteria are delivered into proximity of the surface in a given time unit. 
Also, the binding capacity of the bacterial surface is altered, as new adhesive surface 
proteins and structures come into play. In this way, microbes can form stronger bonds with 
the surface to withstand surrounding flow and adhere in a different way than in static 
conditions. Above border values, with higher shear rates, bacterial adhesion, and biofilm 
retention is decreased, leading to detachment of bacteria and biofilms from the surface 
(Katsikogianni,M, et al. 2006). 
It is also reported that suspended bacteria can respond to shear by altering their growth 
rate, morphology, bacteria size/density and metabolism (Liu,Y and Tay,JH. 2002). 
Additional interactions are progressively formed after the initial bacterial attachment in 
flow conditions. Up to a maximum value, the shear stress required to generate detachment 
increases with incubation time (Ming,F, et al. 1998). 
The ionic strength (electrolytes) and pH value affect bacterial adhesion by changing 
surface characteristics of both the bacteria and the materials (hydrophobicity-charge) 
(Katsikogianni,M and Missirlis,YF. 2004).  The presence of antibiotics decreases bacterial 
adhesion depending on bacterial susceptibility and antibiotic concentration.
Serum or tissue proteins (e.g. albumin, fibronectin, fibrinogen, laminin, denaturated 
collagen) may promote or inhibit bacterial adhesion in binding to substrata and to the 
bacterial surface, or being present in the liquid medium during the adhesion process. For 
the latter situation, most of the proteins have been shown to inhibit bacterial adhesion 
(Brokke,P, et al. 1991), possibly by their association with the bacterial cell surface, the 
material surface or both. Proteins may change bacterial surface physicochemical 
characteristics and in this way alter the adhesion process (An,YH and Friedman,RJ. 1998, 
Pascual,A, et al. 1986). Usually, the bindings between bacteria and proteins are specific 
ligand-receptor interactions. ECM protein Fibronectin (Fn) has been shown to promote 
binding of S.aureus (Kuusela,P, et al. 1985) to the substratum and play a major role in 
foreign body infections (Vaudaux,P, et al. 1984). Regarding the effect of Fn on 
S.epidermidis binding, controversial results exist (Herrmann,M, et al. 1988). Albumin has 
clearly inhibited bacterial adhesion to the polymer (Hogt,AH, et al. 1985, Pascual,A, et al. 
1986), ceramic (Gibbons,RJ and Etherden,I. 1983), and metal (An,YH, et al. 1996, 
An,YH, et al. 1995) surfaces. This inhibition of bacterial adhesion by albumin is thought 
to involve binding to bacterial cells or alteration of the substratum to be more hydrophilic 
(Fletcher,M and Marshall,KC. 1982). A serum protein fibrinogen has been reported to 
enhance adhesion of bacteria and especially staphylococcal adhesion to biomaterials 
(Cheung,AL and Fischetti,VA. 1990, Herrmann,M, et al. 1988). Serum and plasma have 
shown inhibitory effects on adhesion, mainly due to albumin, while IgG and Fn are less 
efficient (Pascual,A, et al. 1986, Paulsson,M, et al. 1993). Inserted implants encounter 
different cells and tissue elements such as platelets in vivo. Wang et al. reported that 
platelets mediated S.epidermidis adhesion onto hydrophobic PE surfaces (Wang,IW, et al. 
1993).
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In conclusion, the acceleration of bacterial metabolic processes that result in growth 
and biofilm formation after the contamination of a biomaterial surface may be explained 
by several factors. Increased chemical activity (catalysis), the creation of new molecules 
and the presence of free ions released from the biomaterial or as contaminants on the 
biomaterial surface play a role here (Gristina,A, et al. 1987). 
2.3.5 Biofilm formation 
Definition and mechanisms
A biofilm has been defined as a layer of prokaryotic or eukaryotic cells, anchored to a 
substratum (biological or non-biological) and embedded in an organic matrix of biological 
origin (Bos,R, et al. 1999). Even though biofilms are often linked with surface attachment, 
they can also form at interfaces of spatially distinct microenvironments or as suspended 
aggregates of free-floating cells. These aggregated masses may present features similar to 
those of a typical surface-associated biofilm (Costerton,J. 2007, Hall-Stoodley,L, et al. 
2012). Hall-Stoodley et al. suggested the definition of a clinically relevant biofilm as: 
‘aggregated, microbial cells surrounded by a self-produced polymeric matrix, which may 
contain host components’ (Hall-Stoodley,L, et al. 2012).
As structurally complex dynamic systems, biofilms have characteristics of both 
multicellular eukaryotic organisms and diverse ecosystems (Hall-Stoodley,L, et al. 2004). 
Bacteria in biofilms communicate, collectively regulate many physiological activities and 
share metabolic pathways (Donlan,RM. 2002, Dunne,WM,Jr. 2002). Due to the lack of 
proper diagnostic criteria of biofilm infections, the role of biofilms in human disease is 
often not clear. Parsek and Singh (Parsek,MR and Singh,PK. 2003) have proposed four 
criteria for infections of biofilm origin. First, the pathogenic bacteria should be surface 
associated or adherent to a substratum. Second, a direct examination should reveal bacteria 
in clusters embedded in a matrix of bacterial or host constituents. Third, the infection 
should be localized. Fourth, the infection should be resistant to antibiotic therapy despite
the antibiotic sensitivity of the constituent planktonic organisms. 
Planktonic or suspended cells are primarily single cells growing in suspension. Sessile 
cells are attached to surfaces but may be dynamic and move according to the latest 
evidence (Hall-Stoodley,L, et al. 2004). Adhesion to surfaces has been shown to induce 
expression of genes that result in the conversion of cells from planktonic single-cell free-
swimming cells into a complex multicellular and multilayered biofilms on a surface with 
bridging connections between bacterial cells (Heilmann,C, et al. 1996, Mack,D. 1999). 
This change of a phenotype leads to resistance to antibacterial agents, phagocytes, and 
antibodies. Due to altered bacterial metabolism, genetic exchange and slimy barrier 
mechanism of biofilm, microbes become highly resistant to antibiotics in biofilms. Much 
larger concentrations of antibiotics are needed to kill bacteria in biofilm than planktonic 
bacterial cells.
Biofilm matrix consists of bacterial cells, exopolysaccharides, proteins, lipids, teichoic 
acids, extracellular DNA (eDNA) released from dying cells, and other polymers 
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(Arciola,CR, et al. 2012). The most important component of the ECM produced by 
staphylococci is exopolysaccharide PIA (Mack,D, et al. 1996a), although evidence exists 
that in vivo and in vitro staphylococcal biofilms can form without PIA (Rohde,H, et al. 
2007). In the abundance of PIA, other matrix components substitute the missing 
exopolysaccharide. 
PIA is found in biofilm producing Gram-negative bacteria and in many staphylococci. 
Its synthesis is controlled by the intercellular adhesion (icaADBC) locus that is found in 
S.aureus and in S.epidermidis as well as in several other Staphylococcus species 
(Heilmann,C, et al. 1996, Vuong,C, et al. 2004b). In S.aureus and S.epidermidis, the 
expression of ica operon and the production of biofilm have been shown to depend on 
environmental conditions, such as culture media composition and supplementation, 
ethanol, salt stress, iron limitation and anaerobiosis (Arciola,CR, et al. 2012). There is 
even evidence that S.aureus can modulate its metabolism switching from the production 
of a proteinaceous to an exopolysaccharide biofilm matrix, depending on the external 
stimuli (Houston,P, et al. 2011, Vergara-Irigaray,M, et al. 2009).
Teichoic acids on the cell surfaces of Gram-positive bacteria are negatively charged 
and contribute to biofilm formation in staphylococci, probably by interacting with other 
surface polymers and taking part to protein attachment (Gross,M, et al. 2001). S.aureus
and S.epidermidis surface proteins associated with biofilm formation and function have 
been characterized and include protein A, biofilm-associated protein (Bap) and 
fibronectin-binding proteins FnbpA and FnbpB (Joo,HS and Otto,M. 2012). It has been 
recently indicated that in vitro biofilm formation of S.aureus, particularly MRSA may 
depend more on eDNA and proteins, whereas PIA may play a significant role in 
S.epidermidis and methicillin-susceptible S.aureus (Pozzi,C, et al. 2012). 
Biofilm formation can be devided into four stages in the biofilm life cycle. The first 
step involves bacterial adhesion to a surface. Secondly, microcolonies are formed, and the 
third stage describes biofilm maturation. In the final detachment stage, the cells leave the 
biofilm structure to contaminate other surfaces (Abdallah,M, et al. 2014). As biofilm 
formation starts with bacterial adhesion to the substratum, there is overlapping of the 
factors that influence bacterial adhesion and biofilm formation even though they are two 
distinct phenomena. The function and appearance of biofilms in various environments 
may be different, but in the end, they originate from the same sequence of events 
(Escher,A and Characklis,W. 1990, van Loosdrecht,MC, et al. 1990). The development of 
biofilm is a dynamic process involving attachment, adhesion, aggregation, growth cycles 
(proliferation), moving over surfaces, detachment/dispersal, and reattachment (Hall-
Stoodley,L, et al. 2004). 
After initial attachment to the surface, bacteria adhere specifically with receptor-ligand 
and cell-to-cell molecular connections. Microcolonies of one or several species are formed 
as multilayered cellular proliferation proceeds, and more bacteria adhere to sessile 
bacteria, conditioning film or slimy extracellular polysaccharide matrix associated with 
the surface. Bacteria secrete EPS, main constituents of the structural matrix surrounding 
the bacterial cells (Hoiby,N, et al. 2011). This matrix acts as a scaffold that stabilizes the 
three-dimensional structure of a complete biofilm in the maturation phase.  In this phase, 
physiological changes occur within the biofilm, including regulation of pili, flagella, and 
exopolysaccharides. With the altered dormant phenotype, metabolism of sessile microbes 
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slows down, and proteins produced and expressed change as well as genes regulated and 
expressed. The maturation stage is mainly controlled by accessory gene regulator (agr) 
locus and the quorum sensing (QS) system. Otto et al.(Otto,M. 2001, Vuong,C, et al. 2000)
reported for the first time the importance of the agr system in biofilm formation in both 
S.aureus and S.epidermidis. Communication and signaling between bacteria in the 
biofilm, QS, has been suggested to be an essential element of regulation of biofilm life 
cycle, biofilm formation and virulence (Periasamy,S, et al. 2012, Vuong,C, et al. 2000, 
Vuong,C, et al. 2003, Vuong,C, et al. 2004a). Sessile bacteria can signal with each other 
and with closing planktonic microorganisms. 
The bacterial detachment from biofilm can be an active process (dispersal), a passively 
induced mechanical process (through fluid shear) or a chemical process (through agents 
that dissolve EPS matrix) (Hall-Stoodley,L, et al. 2004). The agr system and proteases 
control this detachment phase. Three distinct biofilm dispersal strategies have been found: 
swarming/seeding dispersal, in which individual cells are released into the surrounding 
fluid or the surrounding substratum; clumping dispersal in which aggregates of cells are 
shed as clumps or emboli; and surface dispersal in which biofilm structures move across 
the surfaces. Then, they can start colonization and biofilm formation at other locations 
(metastasis). This can be the beginning of late hematogenous infections in the human body 
at other sites, distant from the primary infection locus. 
In addition to available nutrients and mass transfer due to fluid shear, biofilm 
heterogeneity can also be maintained through the production of diffusible detachment 
factors, which cause localized detachment (Hunt,SM, et al. 2003). When the population 
of microbes exceeds a certain level, and the surface becomes overpopulated, parts of 
biofilm detach and move elsewhere to find new growth platforms. With motile bacteria, 
assisting dispersal, upregulation of motility begins in the center of the biofilm mushroom 
caps. Biofilm dispersal is thought to depend on cell-cell disruptive factors, identified to be 
primarily surfactants controlled by QS. In QS increased cell density triggers changes in 
gene expression and it has been associated with a significant number of developmental 
processes including the regulation of biofilm formation and maturation. 
The structure of biofilms changes through mass transfer, genetic regulation, and 
selection depending on available nutrients and environmental conditions. In fast-moving 
waters, biofilms form filamentous microcolonies called streamers and in calm waters 
mushroom-like structures. Biofilms grown in flow conditions show viscoelastic (elastic: 
solid-like and viscous: liquid-like) behavior. They can withstand the temporary periods of 
rapidly changing shear stresses common in marine and river environments (Klapper,I, et 
al. 2002, Stoodley,P, et al. 2002). Observation of biofilms growing in nature and the results 
of in vitro work show, that both the environment and the genome influence biofilm 
formation and development (Hall-Stoodley,L, et al. 2004). 
2.3.6 Race for the surface
The competition between bacterial cells and host tissue cells on an available surface 
for colonization always occurs when an implant is inserted in the human body. Anthony 
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Gristina referred to this competition as "the race for the surface" (Gristina,AG. 1987). A 
bare biomaterial surface is first coated with ECM and plasma proteins, as a conditioning 
film forms. In the next step, the race for the available surface begins, which determines 
whether the host cells or microbes adhere first to the substratum. If host tissue cells win 
the race and colonize the surface, the closing bacteria will face integrated viable host 
tissues with efficient defense systems and mechanisms. In this way, bacterial colonization 
would be less likely to occur, and an infection could be prevented. If bacterial cells adhere 
to the surface before tissue cells, an infection is more likely to establish as primary 
colonizers can recruit other bacteria to the surface and host defense systems can be 
compromised due to the formation of immuno-incompetent microzone. This axiom means 
that implant surfaces with excellent biocompatibility and antibacterial properties at the 
same time would be the optimal choice for the prevention of device-related infections. 
Such surfaces would allow human tissue cells to adhere and grow on them but would 
inhibit bacterial adherence and biofilm formation. The race for the surface concept has 
been experimentally evaluated by Subbiahdoss et al. (Subbiahdoss,G, et al. 2009) and the 
work in this field continues (Perez-Tanoira,R, et al. 2017, Yue,C, et al. 2015, Zhao,B, et 
al. 2015). 
2.3.7 Methods for investigating bacterial adhesion and biofilm formation 
2.3.7.1 Static and dynamic testing of bacterial adhesion 
Bacterial adhesion studies can be done either in static conditions or dynamic flow 
systems. A surface is overlaid or overflown with a suspension of bacteria for a 
predetermined period. Microbes can be visualized in real time, or not adherent microbes 
are separated by rinsing or centrifugation, after which the adhered bacteria are visualized 
and counted. In static experiments usually commercially available flat surfaces like plastic 
culture tubes, petri dishes, tissue culture plates or chemotaxis chambers function as 
platforms for bacterial adhesion. Otherwise, microbes adhere onto substrata placed into 
these petri dishes, culture tubes and culture plates (An,YH and Friedman,RJ. 1997). Under 
dynamic flow conditions, bacterial adhesion can be tested by several methods. A flow cell 
perfusion model (Yu,JL, et al. 1996), rotating disc apparatus (Rutter,PR and Abbott,A. 
1978), parallel plate flow chamber (Rutter,P and Leech,R. 1980), radial flow chamber 
(Duddridge,JE, et al. 1982) or Robbins device (McCoy,WF, et al. 1981) have been used.  
In these systems, an oriented fluid flow brings bacteria to the material surfaces. Real-time 
observation is possible with certain experimental settings (Yu,J, et al. 1994). Controlled 
shear and mass transport, a high data density in time and no air-liquid interface passages 
over the adhering bacteria are the advantages of flow systems (Busscher,HJ and van der 
Mei,HC. 1995). 
Microscopy can be used for counting and morphological analysis of adherent bacteria, 
as in light-, image-analyzed epifluorescence-, scanning electron-, confocal laser scanning, 
and atomic force microscopy. Viable bacteria counting methods such as Colony Forming 
Unit (CFU) plate counting, radiolabelling, and staining are useful in the assessment of the 
viability of the microbes. Other direct and indirect methods such as spectrophotometry, 
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Coulter counter, Time-of-Flight Secondary Ion Mass Spectrometry (ToF-SIMS) and 
biochemical markers add to the repertoire of possible examination tools.
Light microscopy is a basic method for bacterial enumeration and observation. It is 
used to observe bacteria and biofilm directly (Trulear,MG and Characklis,WG. 1982) or 
through a histologic section, with paraffin-embedded biofilms that are cut into histologic 
sections (Chang,CC and Merritt,K. 1992).
Most reliable tool for the observation of smooth and opaque, like metal, plastic or 
ceramic surfaces is Image-analyzed epifluorescence microscopy (IAEFM), based on 
fluorescence stained samples (An,YH, et al. 1995). When combined with epifluorescence 
or fluorescence microscopy, immunofluorescence stainings can be used to assess surface 
attached bacteria. Specific antibodies are produced by immunization of animals and are 
conjugated with fluorescence stains. Even in the presence of other strains or species, it is 
possible to enumerate and identify specific attached bacteria (An,YH and Friedman,RJ. 
1997). Epifluorescence microscopy has several advantages. It is very quick, reducing the 
time required for visual counting by 85% (Sieracki,ME, et al. 1985) and it is suitable for 
large sets of samples. Additionally, epifluorescence microscopy can reduce the possibility 
of operator bias, and it makes direct observation and enumeration possible for attached 
bacteria on opaque surfaces (An,YH and Friedman,RJ. 1997). With individual 
fluorochromes, it allows differentiation between live and dead bacterial cells on the 
surface.  Image analysis systems have been used for determining the number of adherent 
cells, area coverage, and biovolume of attached cells as well as the real-time evaluation of 
attachment, detachment, and growth on the surfaces. 
2.3.7.2 Biofilm examination 
Infected implants or infected or dead bone surfaces can be the sources of biofilms 
harvested for in vivo experiments (Vaudaux,P, et al. 1989). These biofilm samples 
represent better conditions prevailing in the human body but are more complicated due to 
the presence of proteins, tissue cells or debris mixed in a biofilm. Implants together with 
adherent bacteria can be inserted into animals for biofilm studies in vivo and left in animal 
tissues for days, weeks or even months before sacrificion of animals for biofilm 
evaluation. Bacteria can also be injected into the implant site after implantation (An,YH 
and Friedman,RJ. 1997).
To recognize bacterial biofilm the adherence tube test is applied (Christensen,GD, et 
al. 1982). In this approach, biofilm lining the inner surface of the tube is monitored. It has 
been used widely as a screening method for slime-producing bacteria. A turbulent flow 
system, rotating disk reactor and radial flow reactor have been used to study biofilm in
vitro in dynamic conditions (An,YH and Friedman,RJ. 1997). Different methods are 
available for biofilm evaluation and quantification ranging from microtiter plate 
attachment testing to biofilm reactors and from microscopic evaluation to mathematical 
evaluation of images acquired by Confocal Laser Scanning Microscopy (CLSM).
The thickness of the biofilm can be calculated using light microscopy or scanning 
electron microscopy (SEM). Then the dry biofilm mass can be utilized with the thickness 
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and surface area measurements to obtain the density of the biofilm sample (An,YH and 
Friedman,RJ. 1997). Directly or through histological sections, light microscopy enables 
biofilm observation morphologically. The structural properties of a biofilm are viewed 
with SEM and transmission electron microscopy (TEM). One must consider that SEM and 
TEM require sample preparation. Morphologically CLSM is superior in its ability to 
examine biofilm in situ in hydrated conditions; also three-dimensional structures are 
visualized with optical sectioning of the samples (Lawrence,JR, et al. 1991, Qian,Z, et al. 
1996). CLSM uses fluorescent molecular probes and laser beams with a broad range of 
applications in biomedical research. The distribution of bacteria or the thickness of the 
biofilm and the viability of bacterial cells can be assessed. Environmental scanning 
electron microscopy (ESEM) enables the observation of wet samples what makesthe 
sample preparation minimal. There has been interest in applications of ESEM in 
biomaterial sciences (Manero,JM, et al. 2003).
Various methods provide variety of information on biofilm content. The method by 
Christensen et al. enables studies of the relative production of slime by different strains 
and species of coagulase-negative staphylococci. Additionally, evaluation of effects of 
various conditions such as antibiotic exposure on slime production (Christensen,GD, et al. 
1985) can be evaluated. Extracellular slime substance of S.epidermidis has been analyzed 
with an immunochemical method developed by Kotilainen et al. (Kotilainen,P, et al. 
1990). Radiolabelling has been used to measure the biofilm quantitatively (Hussain,M, et 
al. 1992) by growing coagulase-negative staphylococci in a medium containing [14C] 
glucose, which leads to the labeling of the extracellular polysaccharide.
There are difficulties in studying surface-associated bacteria in biofilms compared to 
planktonic microbes. More work and time are needed to culture bacteria as biofilms, as 
heterogeneity of spatial distribution leads to the formation of localized zones, where both 
physiological conditions and cellular physiologies vary widely over subtle distances.  
Moreover, the mass transfer (diffusion and flow through biofilm) and fluid forces (shear 
and drag) can have influence on biofilm in bacterial surface cultures (Hall-Stoodley,L, et 
al. 2004).
2.3.8 Fighting joint implant infections
2.3.8.1 Antibacterial biomaterials
An anti-infective biomaterial is defined as a biomaterial, which has the property to 
prevent or, reduce the infection caused by pathogens of any type (generically including 
viruses, bacteria, fungi, protozoa or other pluricellular pathogens such as helminths) 
(Campoccia,D, et al. 2013b).   In recent years, biomaterial science has taken significant 
leaps in design and development of anti-infective biomaterials, which is reflected in many 
research papers related to these topics. With current improvement of aseptic surgical 
techniques and procedures, adequate preparation of the patient, hygienic protocols, 
laminar air-flow, good antibiotic prophylaxis and postoperative wound care it seems that 
anti-infective biomaterials offer a rational and desirable solution in the prevention of 
medical device-related infections and could lower the risk of these complications further. 
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By definition, antibacterial biomaterials have bactericidal properties, inhibit bacterial 
growth or hinder bacterial colonization. Various strategies are available in the 
development of a biomaterial with antibacterial properties:  1) bacteria-repelling and 
antiadhesive surfaces; 2) intrinsically bioactive materials with antibacterial properties; 3) 
bioactive antibacterial coatings; 3) biomaterials delivering antimicrobials; 4) 
nanostructured materials and 5) bioactive molecules interfering with the production of 
bacterial biofilm (Campoccia,D, et al. 2013a). 
The concept of bacteria-repelling and antiadhesive surfaces has a long time been 
related to the adsorption of molecules that increase hydrophilic properties of the material 
surface and compete with the interaction between bacteria and host matrix proteins that 
cover the implant surface. Heparin has been used in anti-adhesive coatings due to its high 
hydrophilic properties (Arciola,CR, et al. 1993, Arciola,CR, et al. 1994). Other examples 
are coatings based on hydrophilic polymeric brushes based on poly (ethylene glycol) 
(PEG) or poly (ethylene oxide) (PEO) (Neoh,KG and Kang,ET. 2011). However, so far it 
has been shown that, generally, negatively charged surfaces, super hydrophobic surfaces, 
super hydrophilic surfaces, and nm-scale surface roughness all reduce bacterial adhesion. 
Some positively charged surfaces also have antimicrobial properties, when appropriate 
materials are coated on a substrate. The DLC and the DLC polymer hybrid coatings tested 
in this thesis belong to this group of bacteria-repelling and antiadhesive surfaces.
Intrinsically antibacterial materials show antibacterial activity in bulk form without 
modifications. In this group can be categorized several metals (e.g. silver, zinc, and 
copper), some polymeric materials (e.g. chitosan and its derivatives) and different 
bioactive glasses. Rarely antimicrobial metals are used as bare bulk biomaterials. Instead, 
they are utilized in nanocoatings, in doped solid or hydrogel materials, in the formulation 
of bioactive alloys and glasses and in form of micro-and nanoparticles. Polymers that 
contain molecules with antimicrobial properties in their molecular structure belong to the 
group of intrinsically antibacterial materials (Neoh,KG and Kang,ET. 2011, Tan,H, et al. 
2012). 
Bioactive antibacterial coatings deliver anti-infective properties without 
compromising the essential bulkmaterial characteristics. They can be based on different 
concepts. Antimicrobial molecules (e.g. triclosan, chlorhexidine) can be fixed on the 
material surface by grafting; polymer coatings can possess functional groups with 
bactericidal activity (e.g. tertiary amines, N-alamines) or polymer coatings may release 
nitric oxide. Also, polymer coatings releasing reactive oxygen species can be used or 
coatings made of substrates that become bactericidal after a process of photoactivation. 
Thin inorganic or organic, single or multilayer, films consisting of or delivering 
antimicrobial molecules can be considered. Finally, nanotechnology can be utilized to 
produce bactericidal nanostructured surfaces or coatings with nanostructured materials 
(Campoccia,D, et al. 2013a). 
In the case of using biomaterials delivering antimicrobial agents, the antimicrobial 
substances can either be incorporated in the bulk or in the coating of a biomaterial.  Several 
methods exist, such as mixing of the substances to the ingredients during the production 
(e.g. in setting cement), binding of substances covalently to functionalized polymeric 
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coatings or incorporation of substances in self-assembling mono/multilayer organic 
coatings. An issue of concern has been the development of antibiotic resistance with sub-
inhibitory concentrations of antibiotics, as the antibiotics released by antibiotic-loaded 
biomaterials diminish over time.  Also, systemic toxicity has been noted in patients having 
antibiotic-loaded orthopedic implants (Campoccia,D, et al. 2010). Nevertheless, antibiotic 
impregnated biomaterials are of great value in certain procedures, such as two-stage 
revision operation of the orthopedic joint prosthesis.
Additionally, systemic and local toxicity (especially with large implant surfaces and 
in the proximity of central nervous system) associated with the release of metal ions such 
as Ag+ silver have guided the research community to search new tools and antimicrobial 
substances. This has led to introduction of antimicrobial peptides (AMPs) as local, rapid, 
selective and broad-spectrum molecules that can be delivered from biomaterials 
(Hancock,RE and Sahl,HG. 2006). Obstacles challenging the utilization of these peptides 
in biomedicine include potential local toxicity, allergy, susceptibility to proteases and pH 
changes and the high cost of peptide production. While clinical trials are under way, 
interest in AMPs is increasing, and new synthetic compounds aiming to minimize 
drawbacks and maximize the bactericidal possibilities are produced (Kang,SJ, et al. 2012). 
One strategy to prevent implant infections with biomaterial science is to produce 
biomaterials, in which anti-adhesive and antimicrobial coatings are combined. This is seen 
in multilayer films constructed by assembling layer-by-layer heparin and chitosan, and 
covalent conjugation of AMPs immobilized onto a hydrophilic polymer (Fu,J, et al. 2005, 
Gao,G, et al. 2011).
As nanostructural features of material surfaces can alter the 3D conformation of 
adsorbed proteins, nanostructured materials can have an impact on host adhesins and 
conditioning film (Montanaro,L, et al. 2008).  Antimicrobial nanoparticles (NPs) are 
gaining interest in the field of nanotechnology, and thin surface coatings can be developed 
at a nanoscale level. NPs are described as regularly or irregularly shaped particles with at 
least a dimension smaller than 100 nm (Campoccia,D, et al. 2013a). Even though metal 
oxides and carbon-based NPs have shown promising antibacterial activity, the current 
knowledge of safety and toxicological aspects of nanomaterials require careful evaluation 
before routine clinical use of these materials. While physicochemical properties and 
functional groups on material surface guide bacterial adhesion, the morphology of the 
surface influences the outcome of the adhesion process and possibly cell metabolism 
(Campoccia,D, et al. 2013a). Specially patterned surfaces can direct the alignment and the 
spatial distribution of bacterial cells.  Lowest adhesion of Gram-negative and Gram-
positive bacteria was seen in vitro on smooth surfaces on nanometric levels (Mitik-
Dineva,N, et al. 2009). 
Many active anti-biofilm substances have been identified that can be grafted on 
biomaterial surfaces or released by adequate systems/coatings (Arciola,CR, et al. 2011). 
Their molecular components have different modes of action. For example, enzymes are 
capable of selective degradation of the extracellular polymeric substance of biofilm (e.g. 
Dispersin B) ; other bactericidal molecules have abilities to destroy even metabolically 
quiescent bacterial cells within biofilms (e.g. certain AMPs). Molecules interfering with 
the QS system and inducing biofilm dispersion (e.g. furanones) and molecules 
downregulating the expression of biofilm extracellular polymeric substances (e.g. N-
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acetylcysteine) or any way reducing biofilm metabolism (e.g. hamamelitannin) 
(Campoccia,D, et al. 2013a) have also been under evaluation.  The differences between 
bacterial species and strain types of the same species and adaptation of the bacterial 
genome are among the few questions debated regarding clinical applications of bioactive 
molecules interfering with the production of bacterial biofilm. Promising results have been 
reported in studies where anti-biofilm strategies have been combined with the regular 
delivery of antimicrobials (Donelli,G, et al. 2007).
2.3.8.2 Host natural response: antimicrobial peptides
2.3.8.2.1 Overview
The AMPs are an ancient and significant part of the host defense and immunity in 
invertebrates, vertebrates, and plants (De Smet,K and Contreras,R. 2005). The two most 
important antimicrobial peptide families in humans and other mammals are defensins and 
cathelicidins. AMPs are short peptides with broad-spectrum activity against a broad range 
of bacteria, fungi, viruses, parasites and even cancerous cells (Wang,G. 2014). They are 
highly reactive to infectious agents and innate immunostimulatory molecules and exhibit 
immunomodulatory properties. AMPs are chemotactic for leukocytes and nonimmune 
cells at nanomolar concentrations (Auvynet,C and Rosenstein,Y. 2009). They work in a 
cooperative way by leading effector cells to the site of inflammation, modulating the local 
immune response and directing the order of appearance of the different players in different 
scenarios (Auvynet,C and Rosenstein,Y. 2009). AMPs indirectly support chemotaxis by 
inducing the secretion of chemokines (Scott,MG, et al. 2002, Tjabringa,GS, et al. 2003). 
Antimicrobial peptides can be both pro- and anti-inflammatory depending on the situation 
as they protect the host from microbial attacks and at the same time hinder excessive 
immune response (Biragyn,A, et al. 2008, Semple,F and Dorin,JR. 2012).
In May 2014, the current AMP database contained over 2400 AMPs and proteins, with 
98.5% from living prokaryotic and eukaryotic organisms 
(http://aps.unmc.edu/AP/main.php). It is reported that approximately 10% of available 
AMPs are anionic peptides, and 90% are cationic peptides. With the progress of antibiotic 
resistance to multiple antimicrobial agents, new therapeutical tools are needed. Microbial 
resistance against AMPs is rare. Therefore, AMPs are considered promising in the search 
for novel therapeutical applications (Batoni,G, et al. 2016, Martin,L, et al. 2015). In 
diagnostics, the potency of AMPs has also been noted (Deirmengian,C, et al. 2014, 
Deirmengian,C, et al. 2015, Matsen Ko,L and Parvizi,J. 2016). So far high costs and some 
setbacks in clinical trials and commercializing attempts have delayed bringing AMPs to 
the pharmaceutical market. Nevertheless, substantial progress is made in response to 
increased antibiotical resistance and the emergence of new pathogens (Fox,JL. 2013, 
Gordon,YJ, et al. 2005).
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2.3.8.2.2 Defensins 
Defensins are small, cationic and cysteine-rich peptides secreted in many species 
including humans and other mammals, fishes, birds, filamentous fungi, and plants. They 
??????????????????????????????????????????????????????????????????????????????????????-
?????-defensins) based on unique amino acid sequences and disulfide connectivities. The 
antimicrobial action of granulocytes, mucosal host defense in the small intestine and 
epithelial host defense in the skin and elsewhere have been associated with the defensins. 
In vivo experiments report that defensin molecules are important in antimicrobial defense 
(Morrison,G, et al. 2002, Salzman,NH, et al. 2003, Taylor,K, et al. 2008, Wilson,CL, et 
al. 1999).
Microbial signals, developmental signals, cytokines and some neuroendocrine signals 
mediate defensin synthesis and release (Ganz,T. 2003). Antimicrobial activity of defensins 
has been linked to permeabilization of target membranes; several theories exist, but the 
exact mechanism is unclear (Brender,JR, et al. 2012, Ganz,T. 2003, Lichtenstein,A. 1991). 
There have also been reports about specific microbial resistance against antimicrobial 
peptides/defensins (Joo,HS and Otto,M. 2015, Lai,Y and Gallo,RL. 2009, Peschel,A and 
Sahl,HG. 2006). However, as antimicrobial peptides are human body´s natural antibiotics 
preserved through evolution; it is thought that this resistance is rare compared to that 
prevailing against common antibiotics. Further studies will bring more valuable 
information regarding this subject. 
???????????-defensins (hADs) 1-4 are mainly found in neutrophils but also expressed 
in natural killer (NK) cells, monocytes, and some T lymphocytes subsets. hADs 5 and 6 
were detected first in Paneth cells of the small intestine and additionally both in respiratory 
and gynecological tracts. 
???????????-defensins (hBDs) 1-4 are mainly secreted by a large variety of mucosal 
epithelia such as those lining urogenital, gastrointestinal and respiratory tracts (De Smet,K 
and Contreras,R. 2005). hBDs have crucial functions in innate immunity as the first line 
of defense and are associated with various infectious and inflammatory states. They have 
broad-spectrum of antimicrobial activity against Gram-negative and Gram-positive 
bacterial strains, fungi, some parasites and enveloped viruses and low drug resistance 
(Semple,F and Dorin,JR. 2012). hBDs are produced either constitutively or in response to 
infection and tissue injury (Dhople,V, et al. 2006, Wang,G. 2014).
hBD-1 was first isolated from the hemofiltration of patients undergoing dialysis 
treatment (De Smet,K and Contreras,R. 2005). hBD-1 is synthesized by epithelia that are 
in direct contact with the environment or microbial flora (lung, mammary gland, salivary 
gland, kidney, pancreas and prostate epithelia) (Bensch,KW, et al. 1995). hBD-2 has been 
associated with similar locations although it has also been found in skin, leukocytes, 
urogenital system, gut and bone marrow. hBD-2 was first isolated from a psoriatic skin 
lesion (Harder,J, et al. 1997). hBD-1 is reported to be synthesized constitutively while 
hBD-2 expression has been shown to be upregulated by exposure of epithelial cells to 
lipopolysaccharide (LPS) or pro-inflammatory cytokines (tumor necrosis factor alpha 
(TNF-????????????????? 1 beta (IL-?????(De Smet,K and Contreras,R. 2005, Harder,J, et al. 
1997). hBD-3 has been detected in epithelia and non-epithelial cells in the heart, liver, 
skeletal muscle, leukocytes, and placenta (Garcia,JR, et al. 2001a, Harder,J, et al. 2001, 
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Pazgier,M, et al. 2006). It was first isolated from human lesional psoriatic scales (De 
Smet,K and Contreras,R. 2005). hBD-3, like hBD-2, and is also induced by inflammatory 
stimuli and contact with bacteria. 
?????????????-defensin genes (hBD-4-6) were found with the Basic Local Alignment 
Search Tool (BLAST) bioinformatics and functional genomic analysis in the region 8p23 
of human chromosome (Garcia,JR, et al. 2001b, Yamaguchi,Y, et al. 2002). These 
defensins are less known; hBD-4 is present in testis, epididymis, lung tumor tissue and 
gastric epithelial cells (Auvynet,C and Rosenstein,Y. 2009, Shestakova,T, et al. 2008).
Yamaguchi et al. 2002 suggested classification of the hBDs in two groups: the 
epididymis-specific isoforms (hBD 4-6) and the other isoforms (hBD1-3) (Yamaguchi,Y, 
et al. 2002). 28 new hBD genes were discovered by using a computational search tool 
based on hidden Markov models in combination with BLAST (Schutte,BC, et al. 2002).
??? ???? ????? ?????????? ????? ???? ?????????? ??? ?-defensins might reach beyond their 
antimicrobial activity to roles in development, wound healing, fertility, and cancer 
(Semple,F and Dorin,JR. 2012). In literature, the defensins have been linked to antitumor 
activity (Lichtenstein,A, et al. 1986), stimulation of cell proliferation (Murphy,CJ, et al. 
1993), interference with signal transduction pathways (Charp,PA, et al. 1988), 
chemoattraction of immune cells (Territo,MC, et al. 1989) and stimulation of cytokine and 
adhesion molecule expression (Chaly,YV, et al. 2000).
2.3.8.2.3 hBD-3
???? ?????? ?-defensin-3 (hBD-3) expression is influenced by bacterial-derived 
molecules, cytokines, and chemokines produced by the immune system or damaged cells, 
which reflects the time and site-specific, on-demand utilization of this defensin in various 
scenarios considered hostile for the human body. Interestingly, hBD-3 has a broader 
spectrum of antimicrobial activity than hBD-1 and hBD-2, which are effective against 
Gram-negative bacteria and some fungi. hBD-3 is active also against Gram-positive 
bacteria and even kills or inhibits the growth of the opportunistic pathogenic yeast, 
Candida Albicans and some multidrug-resistant clinical isolates such as vancomycin-
resistant Enterococcus faecium (VER) and MRSA. hBD-3 was initially isolated from 
lesional psoriatic scales and has been cloned from both keratinocytes and lung epithelial 
cells. It was found when human epithelial cells were screened for endogenous S.aureus-
killing factors (Dhople,V, et al. 2006, Feng,Z, et al. 2005, Harder,J, et al. 2001, Lee,JK, et 
al. 2013). hBD-3 acts in a salt-insensitive manner what is unusual for defensins (Harder,J, 
et al. 2001). High net charge and hydrophobicity of hBD-3 have been linked to its 
antimicrobial activity (Kluver,E, et al. 2005). 
No cytotoxicity with hBD-3 has been recognized, which has been explained by 
differences in the membrane structures of microbial cells and eukaryotic cells and different 
affinities of hBD-3 to them. While human eukaryotic cells have neutral zwitterionic 
cholesterol and phospholipids in their outer membranes which hBD-3 binds weakly, 
bacterial cell membranes have anionic phospholipids that cationic defensins find attractive 
(Brender,JR, et al. 2012).
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hBD-3 is chemotactic to cells important in septic and aseptic loosening of the implant, 
such as neutrophils, monocytes, and macrophages, through binding to chemokine receptor 
type 2 (CCR2) (Garcia,JR, et al. 2001a, Rohrl,J, et al. 2010). hBD-3 has also been 
suggested to bind chemokine receptor type 6 (CCR6) (Wu,Z, et al. 2003), but this is still 
disputed (Soruri,A, et al. 2007). hBD-3 activates monocytes and myeloid dendritic cells 
via Toll-like receptors 1/2 (TLR1/2) (Soruri,A, et al. 2007) and can also bind TLR9 
intracellularly after penetration of the membrane similarly to cell-penetrating peptides 
(CPPs) (Henriques,ST, et al. 2006). TLRs have been linked to both aseptic and septic 
loosening of prostheses due to their interaction with pathogen-associated molecular 
patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Takagi,M, et al. 
2007, Tamaki,Y, et al. 2009).
hBD-3 has been shown to be involved in wound healing (Sorensen,OE, et al. 2003, 
Sorensen,OE, et al. 2006), as the secretion of hBD-3 and other antimicrobial peptides by 
human keratinocytes was found in sterile wounds and microbe-induced wounds. 
Additionally, hBD-3 has been discovered in the synovial membrane of osteoarthritis, 
psoriatic arthritis (Paulsen,F, et al. 2002) and rheumatoid arthritis (Bokarewa,MI, et al. 
2003) patients without signs of infection, suggesting a role in sterile tissue inflammation 
states. As hBD-3 is secreted upon induction in inflammatory scenarios, it was not found 
in a healthy synovial membrane in contrast to the presence of hBD-1 (Paulsen,F, et al. 
2002). 
Recent interest has been towards the introduction of hBD-3 as an antimicrobial 
therapeutical tool and evaluation of its possible role in diagnostics. hBD-3 has been 
considered  for diagnosis of PJI (Matsen Ko,L and Parvizi,J. 2016). Formalin-fixed and 
paraffin-embedded tissue sections were analyzed using indirect immunofluorescence and 
mean optical density. Samples from septic loosening showed the highest values of hBD-
3, followed by aseptic loosening, the spacer group, and healthy controls (Liu,GD, et al. 
2014). This indicates a local increase in the proportion and/or intensity of staining of hBD-
3 immunoreactive cells around septically loosened implants. Gollwitzer et al. studied the 
presence of hBD-3 in synovial fluid in septic and aseptic loosening. Increased 
concentrations of hBD-3 were found in synovial fluid of septic loosening patients 
compared to aseptic loosening group (Gollwitzer,H, et al. 2013). As an antimicrobial 
agent, hBD-3 was more effective in comparison with vancomycin and clindamycin 
(Huang,Q, et al. 2012). hBD-3 showed antimicrobial and antibiofilm activity against two 
different MRSE and MRSA, as reported by Zhu et al. (Sutton,JM and Pritts,TA. 2014, 
Zhu,C, et al. 2013).
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3. THE AIMS OF THE STUDIES    
The aim of this thesis was to obtain more information of interaction between microbes 
and different biomaterials and the localization of hBD-3 in peri-implant tissues in septic 
joint implant loosening. The following questions were addressed:
-to test the bacterial adhesion inhibition ability of DLC compared to conventional 
biomaterials used in orthopedics in the presence of serum 
-to compare DLC and two novel DLC polymer hybrid coatings to biomaterials 
traditionally used in orthopedics for their ability to inhibit S.aureus and S.epidermidis 
adhesion under dynamic flow conditions
-to compare DLC and two novel DLC polymer hybrid coatings to biomaterials 
traditionally used in orthopedics for their ability to resist S.aureus and S.epidermidis 
biofilm formation
-to identify the cellular sources of hBD-3 expression in septic joint implant loosening 
with peri-implant tissue samples
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4. MATERIALS AND METHODS 
This thesis consists of four studies related to PJI.  Three of them (I, II and IIII) are 
focused on the evaluation of bacterial adhesion and biofilm formation on novel implant 
coating materials in comparison to commonly used implant materials. The fourth study 
(IV) evaluates the cellular sources of hBD-3 expression in peri-implant tissues of septic 
joint implant loosening patients. 
Table 2. Summary of Materials and Methods
Ta : tantalum, Ti : titanium, Cr : chromium, DLC : diamond-like carbon, DLC-PDMS-h : 
diamond-like carbon polydimethylsiloxane hybrid, DLC-PTFE-h : diamond-like carbon 
polytetrafluoroethylene hybrid, UV-lithography : ultraviolet-lithography, FPAD : filtered 
pulsed arc discharge method, DC sputtering : direct-current sputtering, CLSM : confocal 
laser scanning microscopy, IHC : immunohistochemistry, IF : immunofluorescence, FCS: 
fetal calf serum.
4.1 Biomaterial processing
The biomaterial samples were prepared on Si wafers. UV-lithography was used for 
patterning (Study I), and the coatings were deposited using the direct-current (DC) 
sputtering technique for metals (tantalum, titanium, and chromium) and FPAD method for 
DLC and DLC polymer hybrid films (Studies I, II and III). 
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4.1.1 Silicon wafers (Studies I, II and III)
Silicon wafers (p-type, single crystal <100>) 101.6 mm in diameter and 0.68 mm thick 
(Okmetic, Vantaa, Finland) were used in the dynamic adhesion study and 101.6 mm in 
diameter and 0.5 mm thick (Okmetic, Vantaa, Finland) in the static adhesion assay. In 
biofilm study, 0.25 mm thick and 127 mm in diameter, silicon wafers (Si-Mat, Landsberg 
am Lech, Germany) were used. Before the deposition, silicon wafer surfaces were cleaned 
using argon sputter (SAM-7kV, Minsk, Belarus) in the vacuum. The initial vacuum 
chamber pressure was 8x10-4 Pa. The sputtering time was 10 min, and the voltage and 
current used were 5 kV and 30 mA, respectively. During the argon sputtering the vacuum 
chamber pressure was 0.01 Pa. The purity of argon was 99.999% (Instrument Argon 5.0, 
Oy AGA Ab, Espoo, Finland). After the argon sputtering, all deposition processes were 
continued without breaking the vacuum.
4.1.2 Ultraviolet-lithography (Study I)
UV-lithography was used in microfabrication in the first study to pattern parts of a thin 
film or the bulk of a substrate. A geometric pattern from a photomask was transferred to 
a light-sensitive chemical "photoresist" on the substrate. CleWin layout software 
(WieWeb software, Hengelo, The Netherlands) was used to design the photomasks, and 
the masks were fabricated using laser scanning technique by Mikcell Ltd. (Ii, Finland) on 
101.6 mm glass plates with structured chrome layer. 
For bacterial adhesion study, 10 mm x 10 mm sample chips were divided into four 4 
mm x 4 mm areas. One of them was an unpatterned reference, and three were patterned 
with spots of different diameters (5, 25 or 125 μm). Regardless of the diameter of the 
spots, they coated 30.6% of the total surface area of the patterned quadrants. Sample chips 
were fabricated as follows: a) biomaterial spots on Si background and b) Si spots on 
biomaterial background.
20% hexamethyldisilazane (HMDS, Semiconductor Grade Puranal, Riedel-de Haen 
Laborchemikalien GmbH, Seelze, Germany) in xylene was spin coated on the cleaned and 
dried silicon wafers to establish adhesion between silicon wafers and photoresist. For this 
work, Epoxy-based negative photoresist SU-8 2003 (MicroChem, Newton, MA) was
exposed to 365 nm UV light (Karl Suss MA45, Suss Microtec Inc., Waterbury Center, 
VT, USA) through the photomask. Unexposed SU-8 areas were removed using propylene 
glycol methyl ether acetate (PGMEA, Sigma-Aldrich, St.Louis, MO, USA) immersion, 
and sample chips were cleaned with isopropanol and deionized water in an ultrasonic bath 
(Madou,M. 1997, Voldman,J, et al. 1999). 
4.1.3 Direct-current sputtering (Studies I, II and III)
Two physical vapor deposition (PVD) methods were used for deposition of thin films 
on silicon wafers: DC sputtering and FPAD method. DC sputtering is a physical method 
that was used to deposit thin films of metals on a substrate surface. High-energy ions are 
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produced in gaseous plasma and accelerated to bombard the solid sputtering metal target. 
The collision of high-energy Ar+ ions with the metal target detaches atoms from it. They 
are then ejected and hit the substrate to be coated so that a thin film of the source material 
forms on the surface of the substrate. 
More specifically, the Stiletto Series ST20 DC sputtering device (AJA International 
Inc., North Scituate, MA, USA) was used. To enable ignition of the plasma, the pressure 
was maintained in the range of 10-3 Pa. A negative target potential up to 400-500 V was 
applied in DC sputtering to accelerate the positively charged Ar+ ions to the metal target. 
The impacting Ar+ ions removed material from the Ta, Ti or Cr target that was sputtered 
and deposited on the surface of the <100> silicon wafer (Okmetic Ltd, Vantaa, Finland). 
Deposition times for a 200±20 nm thick layer of tantalum, titanium, and chromium were 
approximately five minutes.
4.1.4 Filtered pulsed arc discharge (FPAD) (Studies I, II and III)
FPAD method was used to deposit thin films of DLC and modified FPAD method to 
deposit DLC-PTFE-h or DLC-PDMS-h coatings on the substrate surface (Figure 4.). In 
FPAD, a high-current electric arc strikes the graphite cathode vaporizing material 
(graphite particles, neutral atoms, and plasma ions) from it. This material is then 
accelerated using high voltage through a 90? curved solenoid to filter out large particles 
and neutral atoms before hitting the target material. In modified FPAD a graphite-polymer 
cathode (with the desired polymer) is used.
In this particular FPAD system high purity graphite cathode (99.9%, Carbone
Lorraine, Paris, France), graphite-PTFE and graphite-PDMS cathodes (Irpola Oy, Turku, 
Finland) were used to deposit DLC, DLC-PTFE-h or DLC PDMS-h coatings, respectively, 
on <100> silicon wafer chips.
In the first step, an adhesion layer was deposited using high plasma energies. The main 
portion of the DLC/DLC-PDMS-h/DLC-PTFE-h film was deposited with a low energy 
deposition unit run at 500 V average voltage for 15 minutes. The thickness of DLC, DLC-
PDMS-h, and DLC-PTFE-h films on the silicon wafers was 150 ± 20 nm in dynamic 
adhesion study (Study II) and 200 nm in biofilm study (Study III). In static adhesion assay 
(Study I) the DLC film thickness was 200 nm. The DLC coatings produced were hydrogen 
free and amorphous with high diamond sp3-bond content (85%) (Anttila,A, et al. 1997).
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Figure 4. A schematic presentation of the filtered pulsed arc discharge (FPAD) 
method. Used with permission from: Soininen A. Studies of diamond-like carbon and 
diamond-like carbon polymer hybrid coatings deposited with filtered pulsed arc discharge 
method for biomedical applications. Unigrafia, Helsinki 2015, ISBN: 978-952-9657-78-
0.
4.1.5 The processing of the coated silicon wafers and sample chips (Studies I, II 
and III)
After the coating deposition, silicon wafers were immersed in acetone or resist remover 
bath (mr-Rem 660, Micro Resist Technology GmbH, Berlin, Germany). In the study I, the 
final micropatterns were formed after the biomaterial coating deposited on the top of the 
resist was lifted off with the dissolved resist. 
A device with a custom-made diamond knife was used to cut the silicon wafers into 
individual sample chips. The cutting apparatus was designed in such a way that it did not 
alter the surface chemistry or contaminate the sample chips during the cutting process. For 
static bacterial adhesion (Study I) and biofilm studies (Study III), silicon wafers were cut 
to 10 mm x 10 mm sample chips. For dynamic bacterial adhesion study (Study II), the 
wafers were cut to 15 mm x 30 mm sample chips (to perfectly fit the sample chambers of 
the dynamic testing machine). 
Before the static adhesion assays (Study I), sample chips were rinsed with 70%
ethanol, and gamma sterilized using 28 kGy irradiation at the VTT Technical Research 
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Centre of Finland. The samples were sterilized with ethanol (Ethanol Anhydricum Aa, 
Berner Oy, Helsinki, Finland) before dynamic microbial studies (Study II). Before the 
biofilm experiments (Study III), sample chips were cleaned in 70% ethanol for 45 minutes 
and rinsed with distilled water three times.
For the dynamic bacterial adhesion studies (Study II), biomaterial sample chips 
without serum pre-treatment were used. For the static bacterial adhesion study (Study I) 
and biofilm study (Study III), biomaterial sample chips were incubated in FCS (Perbio 
Science Belgium, Erembodegem, N.V Belgium) for 15 minutes at +37°C to mimic in vivo
conditions. At the next step, the samples were washed three times in 10 mM phosphate 
buffered, 140 mM saline (PBS, pH 7.4). In some static bacterial adhesion experiments, 
patterned sample chips of four different biomaterials were manually fixed on the array 
plates with nail varnish.
4.2 Biomaterial characterization
4.2.1 Surface roughness (Studies II and III)
Average surface roughnesses (Ra) of the coatings were examined with a 2D stylus 
profiler (Sloan Dektak IIa, Veeco Instruments Inc., Santa Barbara, CA, USA) for each 
coating batch (Study II). A mask was placed on the sample for the coating period, and the 
thickness of the coating on the silicon wafer was measured from the step formed after 
removal of the mask.
For biofilm study (Study III), Ra was measured utilizing PSIA XE-100 (Park Systems 
Corp., Suwon, Korea) atomic force microscope (AFM) from randomly selected areas at 
three different locations on six sample chips per group. To scan areas of 2x2 μm over 
sample chips, an aluminum coated Acta-10 (ST Instruments B.V., LE Groot-Ammers, The 
Netherlands) silicon cantilever was used in a non-contact mode. A non-contact mode with 
the scan rate of 0.25 Hz was employed. The results were analyzed using the instrument 
analysis software (XIA).
4.2.2 Contact and sliding angle (Studies II and III)
????????????????c) measurements were done using the static sessile drop method using 
15-20 μl droplets of distilled water and/or diiodomethane. Contact angles were evaluated 
with a CCD video microscope (Study II) and an optical microscope SZ-PT Olympus 
equipped with a digital Olympus Camedia C-3030ZOOM camera (Olympus Corp., 
Tokyo, Japan) (Study III). Five sessile drops per sample chip were processed using  GIMP 
image analysis software (www.gimp.org), which calculated both the left and right contact 
angles from the shape of the drop (Study III). The contact angles of the samples were also 
measured after incubation in FCS (Perbio Science N.N., Erembodegem, Belgium) for 15 
minutes at +37ºC in the biofilm study (Study III). The sliding angles were measured with 
20 μl distilled water droplets in dynamic adhesion study (Study II). The sliding angle is 
defined as the critical angle at which a droplet begins to slide down an inclined plane. The 
accuracy of a single contact or sliding angle measurement was ±0.5°.
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4.2.3 Surface free energy (Study III)
The total SFE and its polar/dispersive components of the sample surfaces were 
obtained. The dispersive ??? and polar ??? components of the surface free energies of the 
biomaterials studied were calculated using Owens-Wendt theoretical model (Owens,DK 
and Wendt,RC. 1969),
(1 + cos?)?? = 2 ?(??????)
?
?  + (??????)
?
?? (3)
Subscripts S and L represent solid and liquid surfaces, respectively. D refers to the 
dispersive component and P to the polar component of the surface tension. Surface tension 
components of the test liquids were ?? = 72.8 mJ/m2, ??? = 21.8 mJ/m2 and  ??? = 51.0 
mJ/m2 for water; and ?? = 50.8 mJ/m2, ??? = 50.8 mJ/m2 and  ??? = 0.0 mJ/m2 for 
diiodomethane (Azeredo,J, et al. 1997). Total surface free energy ?? is the sum of its 
dispersive and polar components. 
4.2.4 Zeta potential (Study III)
Zeta potentials of naive and/or fetal calf serum pre-treated sample chips were measured 
using an electrokinetic analyzer (SurPASS, Anton Paar GmbH, Graz, Austria). An 
electrolyte (0.001 M KCl, pH 7.4±0.5) circulated through the measuring cell. It was forced 
??????????????????????????????????????????????????????????????????????????????????????
and a corresponding movement of the charges in the electrochemical double layer 
occurred causing the zeta potential. Streaming current was measured between two 
?????????????????????????????????????????????????????????????????????????????????????????
calculated from streaming current measurements according to Helmholtz-Smoluchowski 
equation (Lyklema,J. 1995):
? =  ????  × 
?
?×??
 × ?? (4)
??
??   denotes the slope of streaming current versus pressure, ? is the electrolyte 
viscosity, ?? refers to the vacuum permittivity and ? is the dielectric constant of the 
electrolyte. L and A are the length and the cross-sectional area of the streaming channel, 
respectively. This method takes into consideration all conductivity effects, including 
surface conductance, which contribute to the zeta potential.
4.3 Patients and samples for evaluation of hBD-3 expression in septic loosening 
(Study IV)
The cellular origin and expression of hBD-3 were studied with peri-implant tissue 
samples obtained from septic joint implant loosening patients. The patient study group 
consisted of six males and six females, a total of 12 patients with mean age of 72 years 
and range 58-87 years. Samples were obtained during revision operations from active sites 
of the joints from the inner side of the pseudo capsule and/or synovial membrane-like 
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interface membrane. Septic hip implant loosening was confirmed in seven patients, and 
five patients had septic knee implant loosening (Table 3.).
The samples were placed in 10% neutral formalin after removal, and after 24 hours 
they were dehydrated in an increasing ethanol series, cleared in xylene, embedded in 
paraffin and finally stored at room temperature.  The informed consent form was signed 
by all the patients. The local Institutional Review Board of Orthopedic Hospital and the 
Slovenian Medical Committee (No 40/06/11) approved the study entitled "Evaluation of 
different methods for joint prosthesis infection determinations". In the diagnostic workup, 
the preliminary/working diagnosis was set to septic implant loosening after appropriate 
clinical examination, laboratory testing, and radiological imaging. Septic joint implant 
loosening was confirmed as the diagnosis by intraoperative bacterial cultures. All patients 
had a metal-on-ultra high molecular weight polyethylene (MoP) articulating pairs in 
implants.
4.4 Bacterial cultures 
4.4.1 Static cultures (Study I)
A biofilm producing strain of S. aureus S-15981, kindly provided by Dr. Lasa and 
isolated at the Microbiology Department of the University Clinics of Navarra, Spain, was 
used in the static bacterial adhesion study (Valle,J, et al. 2003). Cultures were done on 
blood-agar plates. At first, twenty colony forming units (CFU) were suspended in ten mL 
of Tryptic Soy Broth (TSB, Bacto Tryptic Soy Broth, Becton & Dickinson and Company, 
Sparks, NJ, USA) and cultured for 24 hours at +37°C. Refreshing of the bacterial 
suspension was done by diluting one mL of the bacterial suspension with nine mL of TSB 
and culturing for 18 hours. At the next step, bacteria were suspended and diluted in PBS 
to final concentration 5x108 CFU/mL according to the McFarland standard (Chapin,KC 
and Lauerdale,T. 2007). This was controlled by dilution plating on blood agar (Trypticase 
Soy Agar, BBL 211047, Becton & Dickson and Company, Sparks, NJ, USA and Mueller-
Hinton Agar (BBL 212257, Becton & Dickinson and Company, Sparks, NJ, USA, 
supplemented with 5% horse blood). Two mL of 5x108 CFU/mL bacterial suspension was 
pipetted to each well containing a biomaterial sample chip. Eight-well culture plates were 
used. In some experiments, 15 mL of the bacterial suspension was pipetted on the 
biomaterial array plates (custom-made glass plates were used to facilitate sample chip 
handling, and four different biomaterials sample chips were attached to bottom of these 
plates with nail varnish, and the whole constructs were placed to ten cm Petri dishes). The 
incubation time for cultures at +37°C was 90 minutes, to allow adhesion of bacteria. 
Finally, individual sample chips or sample chips on array plates were washed three times 
with distilled water to remove non-adherent bacteria. All sample chips or arrays were 
studied in triplicate.
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Table 3. The characteristics of septic loosening patients and associated microbiological 
pathogens. The column about the type of pathogens provides the number of positive 
cultures from the total number of cultures taken. Modified from Levon et al. 2015 
(Levon,J, et al. 2015).  
4.4.2 Dynamic cultures (Study II)
S. aureus S-15981 and S. epidermidis ATCC 35984 strains were selected for dynamic 
bacterial adhesion experiments and transported to the University of Patras, Greece, where 
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the experiments were done. The biofilm forming reference strain S. epidermidis ATCC 
35984 was originally isolated in Tennessee, USA.
The bacteria were stored at -70ºC, in a solution containing 70% TSB (Difco 
Laboratories, Detroit, USA) and 30% diluted glycerol (glycerol/water: 1/1). Ten μL 
aliquots of the frozen bacterial suspension of each strain were cultured on blood agar plates 
overnight at +37°C. The plates were subsequently stored at +4°C. Two to three bacterial 
colonies from the refrigerator stored blood agar plates were incubated in five mL TSB for 
18 hours at +37°C in a rotatory shaker at 120 rounds per minute to produce stationary 
phase bacterial cells. Bacteria were harvested by centrifugation at a centrifugal force of 
2683 x g at +4°C for ten minutes and washed twice with a phosphate buffered saline buffer, 
pH 7.4, with an ionic strength of 180 mM, consisting of 100 mM phosphate buffered saline 
supplemented with 80 mM NaCl. Finally, the bacteria were resuspended in the same buffer 
to 1.5×108 CFU/mL concentration according to the McFarland standard (BioMerieux, SA 
Lyon, France).
This was done using optical density measurements of the bacterial suspensions at 550 
nm with a spectrophotometer (Techne, Cambridge, UK).
The parallel plate flow chamber (PPFC) was used to study bacterial adhesion under
dynamic flow conditions. The 30 mm × 15 mm × 1 mm biomaterial sample chip was 
sandwiched between two plexiglass plates in such a way that a 30 mm × 15 mm × 0.35 
mm parallel plate flow chamber was formed. Four syringes were placed in an automated 
syringe pump and connected to four different flow chambers. The pump cycled the pistons 
back and forth every 60 seconds continuously, at which time 3.7 mL were displaced. This 
process cycled for 120 minutes. All experiments were carried out at +37°C, and the shear 
rate was adjusted to 200 s-1. 
The shear rate ? was calculated by the following formula:
? =  ????? (5)
Where Q is the flow rate, W (width of the chamber) = 15 mm and h (height of the chamber) 
= 0.35 mm. Each experiment was performed in three replicates.
4.4.3 Biofilm cultures (Study III)
S. aureus S-15981 and S. epidermidis ATCC 35984 were grown on blood agar plates. 
Twenty CFU were suspended into ten mL of TSB (Bacto Tryptic Soy Broth, Becton & 
Dickinson and Company, Sparks, NJ, USA) and cultured for 24 hours at +37°C. The 
bacterial suspension was refreshed for the experiments by diluting one mL of the bacterial 
suspension with nine mL of TSB, followed by culture for 18 hours. After this, the bacteria 
were diluted and resuspended in TSB to obtain a concentration of 5x108 CFU/mL 
according to McFarland standard (Chapin,KC and Lauerdale,T. 2007). The concentration 
was controlled by dilution plating on blood agar (Trypticase Soy Agar, BBL 211047, 
Becton & Dickson and Company, Sparks, NJ, USA and Mueller-Hinton Agar, BBL 
212257, Becton & Dickinson and Company, Sparks, NJ, USA, supplemented with 5%
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horse blood). Two milliliters of 5x108 CFU/mL of bacterial suspension was pipetted into 
each well of a 12-well plate containing biomaterial sample chips and incubated at +37°C 
for 16 hours. The selected 16 hours incubation time was based on pilot experiments (data 
not shown). After 16 hours of biofilm forming incubation, the sample chips were washed 
three times with 0.9% NaCl before analysis of the biofilm-coated area on the biomaterial 
sample chips. All sample chips were run as duplicates, and the experiments were repeated 
three times with both staphylococcal bacterial strains.
For biofilm viability studies using Live/Dead Baclight staining, bacteria were cultured 
overnight at +37°C in TSB (Bacto Tryptic Soy Broth Becton, Dickinson, and Company 
Sparks USA). The concentration was adjusted to 5x108 CFU/mL in TSB. Two milliliters 
of bacterial suspension per well was added to the eight-well culture plates containing FCS 
(Perbio Science Belgium N.V Belgium) pre-treated biomaterial sample chips on the 
bottom of the wells for 24-hour incubation at +37°C. After this, the bacterial suspension 
was refreshed by aspiration and replaced with fresh TSB. After a total 48 hours of 
incubation, the sample chips were washed three times with distilled water to rinse away 
free bacteria and buffer before Live/Dead Baclight staining.
4.5 Stainings
4.5.1 Acridine Orange staining (Study I)
Acridine Orange 3R nucleic acid selective fluorochromic cationic stain (Chroma-
Gesellschaft Schmid GmbH, Köngen, Germany) was used to visualize adherent S. aureus
cells on patterned sample chips as such or array plates. The sample chips were incubated 
for two minutes in 1:10 000 (w/v) Acridine Orange 3R in 0.2 M acetate buffer, pH 3.8. 
Acridine Orange staining solution was stored in the dark at room temperature. After 
Acridine Orange 3R staining the sample chips were rinsed with tap water before 
epifluorescence microscopy and photographing for morphometric analysis.
4.5.2 Syto 9 staining (Study II)
After dynamic flow adhesion cultures, all sample chips still mounted in the flow 
chambers were rinsed with eight milliliters of buffer solution to remove non-adherent or 
loosely adherent bacteria. Biomaterial sample chips placed in chambers were fixed in 
freshly prepared 3% formaldehyde for 30 minutes at +37°C. Formaldehyde was made by 
adding paraformaldehyde (Sigma, Missouri, USA) in 100 mM sodium phosphate buffer 
at +60°C, followed by drop-wise addition of NaOH until the solution was clear. After 
fixation, the sample chips were stained in one mL (in each chamber) of a freshly prepared 
solution containing two μL SYTO 9 (Molecular Probes Europe BV, Leiden, The 
Netherlands) per one mL of deionized water for 30 minutes at room temperature, in the 
dark. The distribution of adherent bacteria was visualized with Syto 9. Syto 9 penetrates 
the staphylococcal cell membrane and is a fluorescent DNA-binding stain.  After staining 
the sample chips were rinsed three times with distilled water, the chambers were 
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dismounted, and the sample chips placed on object slides and mounted in Gel Mount 
(Sigma, Missouri, USA), an aqueous mounting medium. Finally, the sample chips were 
covered with a coverslip before confocal laser scanning microscopy.
4.5.3 Calcofluor White staining (Study III)
Fluka 18909 Calcofluor white stain (Sigma-Aldrich Chemie GmbH, Steinheim, 
Germany) was pipetted on biomaterial chips containing S. epidermidis and S. aureus 
biofilms for two minutes. Calcofluor white is a fluorochrome stain, and it interacts with 
the polysaccharide components of the biofilm. The biofilms on the surfaces of the 
biomaterial sample chips were washed with 0.9% NaCl three times for five minutes after 
Calcofluor white staining before epifluorescence microscopy.
4.5.4 Live/Dead viability staining (Study III)
Live/Dead Baclight viability staining was used to observe biofilm on biomaterial 
sample chips. With the LIVE/DEAD Baclight Bacterial viability kit (L7012, Invitrogen 
Molecular Probes Eugene, Oregon, USA), a stock dilution was made. In this, equal 
volumes of Syto 9 (nucleic acid stain, excitation 490 nm/emission 522 nm) and Propidium 
Iodide (nucleic acid stain, excitation 490 nm /emission 635 nm) were combined. Viable 
cells are stained green by lipophilic Syto 9, while Propidium Iodide, which penetrates only 
non-viable cells with damaged cell ?????????????????????????????????????????????????????
of such solution, one mL of distilled water was added. The stock dilution was mixed, and 
the sample chips were incubated with it for 15 minutes in the dark at room temperature. 
Distilled water was used to wash the sample chips three times after staining before 
confocal laser scanning microscopy.
4.5.5 hBD-3 immunohistochemical staining (Study IV)
For immunohistochemical staining of hBD-3 in peri-implant tissues of septic implant 
loosening, four μm thick sections were used. The first section was stained with eosin and 
hematoxylin, after which the following sections were used for immunostaining.  A pilot 
titration experiment was run to find the optimal antibody concentrations. In this 
experiment, a serial dilution of the primary antibodies was used to stain five consecutive 
deparaffinized tissue sections. An entirely automatic staining of tissue sections was 
performed with Bond Polymer Refine (DS9800) horseradish peroxidase (HRP) labeled 
polymer method after placement of the sections in a Leica-Bond-Max immunostainer 
(Leica Microsystems GmbH, Wetzlar, Germany). A citrate buffer solution was used for 
antigen retrieval for 20 minutes. According to the staining protocol, the sections were first 
incubated for 30 ??????????????????????????????-purified rabbit anti-human hBD-3 IgG 
(Novus Biologicals, Littleton, CO, USA). After that, the slides were incubated for eight 
minutes in Post Primary and eight minutes in the anti-rabbit Poly-HRP-IgG polymer. Ten 
minutes of incubation in 0.023% 3,3´diaminobenzidine tetrahydrochloride Mix DAB 
Refine was done and finally five minutes of incubation in hematoxylin. A washing buffer 
supplied by the company was used to wash the slides between the steps. Slides were 
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dehydrated and mounted in Mountex (HistoLab, Gothenburg, Sweden). As positive and 
negative staining controls, tissue sections from periodontitis lesions and non-immune 
rabbit IgG (Jackson ImmunoResearch 011-000-003, Suffolk, UK) at the same 
concentration as and instead of the primary rabbit anti-human BD-3 IgG, respectively, 
were used.
4.5.6 Double immunofluorescence staining (Study IV)
For immunofluorescence staining, antigen retrieval was done in citrate buffer pH 6.0 
using a microwave oven for ten minutes at +98°C (??????????? ? ???? ???????????????
Labstation; Milestone Srl, Sorisole, Italy) after deparaffinization of the tissue sections. 
After a wash with PBS three times for five minutes, the slides were permeabilized with 
Triton X-100 for ten minutes at room temperature (RT). Slides were washed with PBS 
three times for five minutes and incubated with 10% normal goat serum for one hour at 
RT.  After the serum blotting, the slides were incubated with four μg/mL affinity-purified 
rabbit anti-human hBD-3 IgG together with one of the selected antibodies. 0.5 μg/mL 
mouse anti-human CD68 IgG1 (DAKO, Glostrup, Denmark), 0.1 μg/mL mouse anti-
human mast cell tryptase IgG1 (MST, AbD Serotec, Oxford, UK), 22.5 μg/mL mouse 
anti-human CD31 IgG1 (DAKO, Glostrup, Denmark) or 10 μg/mL mouse anti-human 
HSP47 IgG2b (StressGen Biotechnologies Corp., Victoria, BC, Canada) was used for 
overnight at +4°C. This was followed by washes in PBS three times for five minutes and 
??????????????????????????????????? ????????????????????????-rabbit IgG and Alexa Fluor 
488 goat anti-mouse IgG (both from Alexa Fluor, Molecular Probes, Leiden, The 
Netherlands) for one hour at RT. Then the slides were washed in PBS three times for five 
minutes and subsequently incubated in 4'6-diamidino-2-phenylindole (DAPI) for ten 
minutes at RT. At the next step, the slides were washed in PBS two times for five minutes 
and in distilled water for five minutes, followed by mounting in Vectashield® mounting 
medium (Vector Laboratories, Burlingame, CA). Non-immune rabbit IgG, mouse IgG1, 
and mouse IgG2b were used for negative staining controls at the same concentrations as 
and instead of the primary antibodies.
4.6 Microscopy
4.6.1 Epifluoscence microscopy (Studies I, III and IV)
Acridine Orange 3R positive bacteria were visualized under an epifluorescence 
microscope (Olympus AX70, Hamburg, Germany) with 460-495 nm excitation and 510 
nm emission wavelength U-MWIB3 FITC filters (Study I). They were photographed using 
PCO Sensicam (PCO AG, Kelheim, Germany) digital camera attached to a computer for 
subsequent morphometric analysis.
Calcofluor white stained biofilms were visualized under an epifluorescence 
microscope (Olympus Optical Co, Tokyo, Japan) using DAPI-filter (Study III). The 
biofilms were photographed with a digital camera (Olympus Optical Co, Tokyo, Japan) 
coupled to an Analysis software program (Soft Imaging System GmbH, Münster, 
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Germany) for subsequent morphometric analysis. 19 images of each sample chip were 
taken from similar locations to represent biofilm coverage on the sample surface.
The immunofluorescence stained tissue sections were analyzed and photographed 
using Leica DM6000 microscope and photographed using DEC420 color camera (Leica 
Microsystems, Buffalo Grove, IL, USA) (Study IV).
4.6.2 Confocal Laser Scanning Microscopy (Studies II and III)
Nikon TE2000-U Confocal Laser Scanning Microscopy (CLSM) system was used 
(Nikon, The Netherlands) to evaluate bacterial adhesion to the sample chips and to 
enumerate the adherent bacteria (Study II). In the system, a laser scanning module was 
mounted on an inverted microscope. The argon laser was utilized, and the images were 
recorded at an excitation wavelength of 488 nm and an emission wavelength of 500 nm. 
Since the adherent bacteria only formed monolayers, a thin section was scanned and saved 
??? ?? ??????? ??????? ???? ??????? ??? ???? ??2 area were chosen randomly, and six non-
overlapping images were taken from each sample chip to eliminate the possible effect of 
a slightly uneven distribution of bacteria (Study II).
Confocal microscopy was done to visualize the morphology of the bacterial biofilms 
and live and dead bacteria using a Leica TCS SP5 (Leica Microsystems, Mannheim 
Germany) microscope with a dipping water immersion objective HCX APO L 63x/0.9 W 
(Study III).
4.6.3 Light microscopy (Study IV)
For localization of hBD-3 in peri-implant tissues in septic implant loosening, the 
analysis and photography of immunohistochemically stained slides were done by using a 
Leitz Diaplan microscope and five megapixels Leica DFC420 digital camera (Leica 
Microsystems, Wetzlar, Germany). Several factors were considered in the analysis of the 
stained sections. The origin of the sample (hip, knee); the type of the pathogen 
(Staphylococci + or -); the survival time of the implant (the time from the primary 
operation to the revision operation) and the gender (female, male). The analysis was done 
separately for the hip and knee joints.
4.7 Quantification of bacterial adhesion and biofilm formation
4.7.1 Static bacterial adhesion (Study I)
To produce images showing areas of equal size of the different surfaces for analysis of 
????????????????????????????????????????????????????????????????????????????????????????
the image below was created in Adobe Photoshop CS2 (Adobe Systems Incorporated, San 
Jose, CA, USA). These images were processed by setting the background black in each 
picture. Individual images were opened in ImageJ 1.37c (National Institute of Health, 
Bethesda, MD, USA) and the bacterial coverage area in each image was calculated using 
the nucleus-counter function of the WCIF plug-in (Abramoff,M, et al. 2004, Rasband,W. 
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2007, Rasband,W. 2007). All results represent triplicates, shown using mean ± standard 
deviation of the mean (SD).
4.7.2 Dynamic bacterial adhesion (Study II)
Digital image analysis of the CLSM pictures and the quantification of adherent 
bacteria were done using the software developed at the University Medical Centre 
Groningen, the University of Groningen in The Netherlands. The software is based on the 
methods described earlier (Meinders,JM, et al. 1992).
SPSS statistical software, version 14.0 (SPSS, Chicago, IL) was used statistically to 
examine the effect of the biomaterial properties on bacterial adhesion.  The Shapiro-Wilk 
(W) test was utilized to analyze the normal distribution of the variables. All variables were 
normally distributed because W was close to one for all of them. Subsequently, one-way 
analysis of variance (ANOVA), and Post-hoc comparisons of all possible combinations of 
group means were done utilizing the Scheffe significant difference test. P<0.05 was 
considered to be significant.
4.7.3 Biofilm coverage (Study III)
All 19 images were analyzed and segmented using Otsu's thresholding method. The 
proportion of bacterial biofilm coverage on the material surfaces was calculated using 
MATLAB (The MathWorks Inc., Natick, MA, USA). One-way ANOVA (SPSS 16.0 
software) variance analysis and Tukey Post-Hoc Tests were applied to determine the 
statistical significance of the differences between groups. P<0.05 was considered as 
significant. 
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5. RESULTS
5.1 Static bacterial adhesion (Study I)
In static bacterial adhesion tests 1) homogenous, non-patterned biomaterial surfaces 
and 2) samples containing the same biomaterials as spots on silicon background (Figure 5
A and B) or, vice versa, providing silicon spots on biomaterial background (Figure 5 C
and D), were compared against each other. The conventional implant materials Ta, Ti and 
Cr and DLC, were studied for their ability to inhibit adhesion of S. aureus bacteria. 
Tantalum and titanium surfaces acted as good adhesion substrates for S. aureus, whereas 
chromium and DLC inhibited bacterial adhesion with almost no bacterial cells adhering 
to them (Figure 5.).
Figure 5.  S.aureus adhesion to microtextured material samples.  The first column 
???????????????????????????????????????????????????????????????????????????????????????
???????? ??? ????????? ???????????? ??????????? ????? ??? ???? ??????? ???????? ???? ???????
biomaterial circles are s???????????????????????????????????????????????????????????? ???
biomaterial background (D). Acridine orange staining, original magnification x 10.
When the bacterial resistance of different biomaterials on silicon background or silicon 
patterns on biomaterial background were compared, the results were clear. S. aureus cells 
grew firmly only on tantalum and titanium patterns or on tantalum and titanium 
background, but not on the silicon patterns or silicon background, which were almost free 
of bacteria. S.aureus adhesion was low on DLC and chromium not dependent on whether 
they formed patterned spots or background. In conclusion, DLC, chromium, and silicon 
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did bind considerably fewer bacteria in all experimental settings when compared to Ti and 
Ta.
The percentage area of the biomaterial covered by adherent bacteria was calculated 
(Figure 6.), and this showed clearly the preference of S. aureus bacteria to tantalum and 
titanium materials over DLC and chromium. 
Figure 6. Static S.aureus adhesion. Adhesion of bacteria to biomaterials (black bars) and 
silicon background (white bars) used as an internal standard in 90-minute long adhesion 
???????????????????????????????????? ?????????????? ???????????????????????????????????????
biomaterials were tested against silicon background and each other. Values are the mean 
± S.D. DLC = diamond-like carbon, Ta = tantalum, Ti = titanium, Cr = chromium.
*Expressed as the percentage of the circular biomaterial area covered by the adherent 
bacteria.
**Expressed as the percentage of the silicon background area covered by the adherent 
bacteria.
The effect of the size of the patterned spots on bacterial adhesion was evaluated. 
Different sized patterns were compared to each other and homogenous biomaterial area. 
Each patterned sample chip contained four different biomaterial areas (quadrants), three
of which had micro-texturized spots whereas one quadrant area was coated 
homogeneously. 125 μm, 25 μm or 5 μm patterned circular spots were compared to the 
material surface without any texture. As the total amount of adherent bacteria on 
chromium and DLC were minimal, the effect of the size of the pattern (texture) on the 
adherence of S. aureus could not be evaluated further using these biomaterials. With Ta 
and Ti, some conclusions could be made. On the sample areas with patterned large 125 
μm and intermediate 25 μm spots bacteria adhered either to a) metal-coated circular areas, 
but were not present on the silicon background or to b) metal background if metal was 
located in the background interrupted by regularly spaced circular silicon spots. In 
contrast, with the small 5 μm titanium and tantalum spots, bacteria did not seem so strictly 
to respect the borders of the circular features against the silicon background (and vice 
versa). S.aureus bacteria adhered both to the metal biomaterial and silicon, on the area 
presenting the small 5 μm features. Finally, on the plain biomaterial surfaces, bacteria 
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were organized to relatively homogenous bacterial coating and formed rather uniform 
mats.
5.2 Dynamic bacterial adhesion (Study II)
S. aureus and S. epidermidis adhesion to biomaterial surfaces in dynamic flow 
conditions was enumerated. The number of bacteria on different materials, counted using 
image analysis software are shown in Table 5. S. aureus adhesion to DLC-PTFE-h and to 
tantalum was significantly (P<0.05) lower than to DLC-PDMS-h (0.671±0.109x107/cm2
and 0.751±0.223x107/cm2 vs. 1.055±0.151x107/cm2, respectively) (Table 4.). No other 
significant differences were detected in performed tests. These results also showed that S. 
epidermidis adhered equally to all materials tested (P<0.05).
Table 4. The numbers of S. aureus S-15981 and S. epidermidis ATCC 35984 bacteria 
adhered on DLC, DLC-PDMS-h, DLC-PTFE-h, Ta, Ti and Cr surfaces after 120 minutes 
of dynamic bacterial adhesion incubation expressed in units 1/cm2. Values are the mean ± 
S.D. DLC = diamond-like carbon, DLC-PDMS-h = DLC polydimethylsiloxane hybrid, 
DLC-PTFE-h = DLC polytetrafluoroethylene hybrid, Ta = tantalum, Ti = titanium, Cr = 
chromium.
The surface roughnesses, contact and sliding angles of the biomaterial samples were 
analyzed to evaluate their effects on bacterial adhesion. The highest contact angle values 
were measured for DLC-PDMS-h and DLC-PTFE-h, which were 104±4° for both; and 
the lowest sliding angle for DLC-PDMS-h, which was 9±1° (Figure 7.). The roughness 
values were 3±2 nm for DLC, DLC-PDMS-h, DLC-PTFE-h samples and 17±3 nm, 19±3 
nm and 25±3 nm for tantalum, titanium, and chromium samples, respectively. 
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Figure 7. Contact angle and sliding angle values of the biomaterials used in dynamic 
adhesion experiments. *denotes that droplet did not start to slide even at 90°. Values are 
the mean ± S.D. DLC = diamond-like carbon, DLC-PDMS-h = DLC 
polydimethylsiloxane hybrid, DLC-PTFE-h = DLC polytetrafluoroethylene hybrid, Ta = 
tantalum, Ti = titanium, Cr = chromium. 
5.3 Biofilm formation (Study III)
5.3.1 Biofilm coverage
The conventional biomaterials Ti, Ta, and Cr, were almost entirely (close to 100%) 
covered by staphylococcal biofilm after 16 hours of biofilm incubation. DLC inhibited 
biofilm formation clearly better than metals and DLC-PDMS-h. 87.71±26.4% of the DLC 
surface area was covered by S. epidermidis biofilm and 81.05±24.1% by S. aureus biofilm 
(Figure 8.). DLC-PTFE-h was the best in the anti-biofilm ranking, with only 55.84±39.4% 
S. epidermidis and 50.52±26.3% S. aureus biofilm surface coverage, P<0.001 for both 
(Figure 8.). The anti-soiling and non-sticky DLC-PDMS-h did not differ in its biofilm 
formation inhibition from the conventional implant materials (Figure 8.). 
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Figure 8. Biofilm surface coverage. The area covered by the biofilm (% of the total sample 
surface area) after 16 hours of S.aureus and S.epidermidis biofilm incubation. Values are 
the mean ± S.D. DLC and DLC-PTFE-h resisted significantly better biofilm formation
compared to other materials (P<0.001)DLC = diamond-like carbon, DLC-PDMS-h = DLC 
polydimethylsiloxane hybrid, DLC-PTFE-h = DLC polytetrafluoroethylene hybrid, Ta = 
tantalum, Ti = titanium, Cr = chromium.
    5.3.2 Surface roughness, contact angle, and surface free energy
The average surface roughness (Ra) values ranged from 0.6 nm to 2.0 nm (Table 5.). 
According to these measurements, all coatings were very smooth (Ra ????????????????????
the mirror-finish surfaces of medical implants.
The contact angles and the total surface free energies, as well as their dispersive and 
polar components for all materials studied, are seen in Table 5. DLC-PTFE-h and DLC-
PDMS-h had the highest water contact angles before serum incubation, 106° and 101.7°, 
respectively (Table 5.). They were followed by tantalum, DLC, titanium and chromium 
within the narrow 64.1?-71.2° contact angle range. Serum protein pre-treatment caused a 
significant (P<0.001) drop in the water contact angles of all studied materials (Table 5.), 
this decrease being greatest (38%) for DLC-PTFE-h.
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Table 5. Average surface roughnesses (Ra??????????????????????????water) and surface free 
energy components for the surfaces of the tested materials. Water contact angles were 
measured both before and after serum incubation. DLC = diamond-like carbon, DLC-
PDMS-h = DLC polydimethylsiloxane hybrid, DLC-PTFE-h = DLC 
polytetrafluoroethylene hybrid.
5.3.3 Zeta potential
The average zeta potential values were negative for all the biomaterials studied (Figure 
9.). Before serum protein pre-treatment, DLC and DLC-PTFE-h had the lowest zeta 
potentials, -88.4 mV and -84.2 mV (p<0.001 for both compared to the other materials), 
respectively. Cr, Ta, DLC-PDMS-h followed within a narrow range from -67.1 to -65.2 
mV. Ti had clearly the highest value (-58.0 mV, P<0.001). Serum protein pre-treatment 
caused a significant (P<0.001) increase in the zeta potentials of all studied materials 
(Figure 9.). This increase was largest for DLC (41%) and DLC-PTFE-h (42%), but only 
17% for DLC-PDMS-h.
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Figure 9. The zeta-????????????????????????????????????????????????????????????????????????
serum. Values are the mean ± S.D. DLC = diamond-like carbon, DLC-PDMS-h = DLC 
polydimethylsiloxane hybrid, DLC-PTFE-h = DLC polytetrafluoroethylene hybrid, Ta = 
tantalum, Ti = titanium, Cr = chromium.
5.3.4 Biofilm viability
In the observation of Live/Dead stained biofilm, using CLSM, viable bacteria 
embedded in the biofilm were seen green and dead bacteria red. Representative samples 
showed uniform results: the viability of the bacteria was higher in the surface layers of the 
biofilm, whereas staphylococci in the deeper layers were dead and red (Figure 10). The 
biofilm landscape formed mushroom-like towers. 
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Figure 10. A cross-section of S.aureus S-15981 biofilm on a biomaterial surface, viewed 
with a confocal laser scanning microscope (CLSM) after 48 hours of incubation. In the 
Live and Dead viability staining, dead bacterial cells are seen in red color and viable cells 
in green color. The bacteria are embedded in extracellular polymeric substance (EPS).
Figure 11. Calcofluor white staining. Calcofluor white stained staphylococcal biofilms 
after 16 hours of incubation seen on DLC-PTFE-h (A), DLC (B) and titanium (C) 
biomaterial samples, epifluorescence microscopy. DLC-PTFE-h was clearly the most 
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resistant to biofilm formation, followed by DLC as second in the ranking order. Titanium 
surfaces were almost entirely covered by biofilm.
5.4 hBD-3 expression in septic joint implant loosening (Study IV)
5.4.1 Immunohistochemistry
In the peri–implant tissue sections of septic implant loosening, hBD-3 negative, 
multilobular, polymorphonuclear neutrophils were seen (Table 6.).  Circulating monocytes 
in the vascular lumen were also hBD-3 negative, but some of the monocyte-like cells in
tissues were instead hBD-3 positive (Table 6.). Foreign body giant cells were very weakly 
hBD-3 immunoreactive or hBD-3 negative (Table 6.), whereas macrophage-like (Table 
6.) cells were frequently hBD-3 immunoreactive. Some variation could be seen in vascular 
endothelial cells lining the vascular lumen as some were hBD-3 immunoreactive (Table 
6.).  Immunoreactivity could be considered in some spindle-shaped stromal fibroblast-like 
cells localized along wavy and collagenous fibrous tissue (Table 6.).  The cellular 
cytoplasm contained most of the hBD-3 staining while some specific hBD-3 staining could 
be seen in the ECM in areas infiltrated by hBD-3 immunoreactive macrophage-like cells. 
The specificity of the extracellular and cellular hBD-3 staining was confirmed with 
positive sample controls of periodontitis and negative staining controls of peri-implantitis 
tissues. 
The hBD-3 immunoreactive cells were more frequent in women than in men regarding 
hip joints, whereas contradictory findings could be seen in knee joints. No clear 
differences in the host hBD-3 response in septic loosening were observed considering the 
presence or absence of staphylococci. Early revisions (max. 3 months) showed a few hBD-
3 immunoreactive cells and foreign body giant cells and substantial numbers of 
neutrophils. Instead, in peri-implant tissues of implants with longer survival times (up to 
over 13 years) there could be seen more hBD-3 immunoreactive cells, often macrophage-
like cells and additionally some slightly hBD-3 immunoreactive foreign body giant cells.
5.4.2 Double immunofluorescence staining
In double immunofluorescence stainings, CD68 immunoreactive macrophages 
contained hBD-3.  While vascular endothelial cells were mostly hBD-3 negative, in some 
areas, there could be seen hBD-3 immunoreactive blood vessels, confirmed by double 
labeling of these cells with hBD-3 and vascular endothelial cell marker CD31 antibodies.  
No colocalization of hBD-3 and HSP47 proteins was seen in double immunofluorescence 
stainings. Also, human mast cell tryptase immunoreactive mast cells did not colocalize 
with hBD-3 positive cells.
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Table 6. Cellular sources of hBD-3 in septic joint implant loosening. Periprosthetic tissue 
??????????????????????????????????????????????????????????????????-defensin-3 (hBD-3). 
Observations were made that the circulating blood leukocytes, such as neutrophils, 
lymphocytes, and monocytes, were hBD-3 negative. The infiltrating macrophages and 
newly recruited monocytes in tissues were hBD-3 positive. The vascular endothelial cells 
were usually hBD-3 negative, but in some areas they were hBD-3 immunoreactive, lining 
the vascular lumen. Fibroblast-like cells were mostly hBD-3 negative, but in some regions, 
they were hBD-3 positive. The foreign body giant cells were very weakly hBD-3 positive, 
and the mast cells were hBD-3 negative. + describes that given cells were hBD-3 positive, 
- refers that given cells were hBD-3 negative, and +/- denotes that both positive and 
negative cells were found.
Cellular sources of hBD-3 in septic joint implant loosening
Endothelial cells +/-
Fibroblasts +/-
Foreign body giant cells +/-
Macrophages +
Mast Cells -
Monocytes +/-
Neutrophils -
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6. DISCUSSION   
6.1 General discussion
Bacterial adhesion, the first step in the implant infection, was evaluated from multiple 
viewpoints (Studies I and II). In the third study of this thesis (Study III) biofilm formation 
following bacterial adhesion was examined.   In the context of implant infections, it is 
relevant to evaluate both phenomena. These infections begin with initial bacterial adhesion 
but often precede to full-scale biofilm infections that are difficult to diagnose and treat. 
The aim was to compare DLC and DLC-p-h to biomaterials traditionally used in 
orthopedics for their ability to inhibit bacterial adhesion and biofilm formation. Well-
established and known methods such as static bacterial cultures, dynamic flow testing, 
stainings, and microscopy were employed in the experimentation. These methods were 
modified according to desired purposes.
      The experimental setups may result in a considerable variation between different 
experiments. Hence comparisons of different studies and interpretation of results are 
challenging. To counter this problem and obtain reliable information about the effect of 
patterning on bacterial adhesion in the static adhesion tests, we used a different kind of 
patterned coatings produced on the same background material, silicon. This allows values 
of various experiments to be normalized. In some experiments, several patterned 
biomaterial chips were attached to an array plate to bypass natural fluctuations. In this 
setting, the number of bacteria per macroarray sample was the same for different 
biomaterials and patterns. 
Considering the statistical methods used, the one-way analysis of variance (ANOVA) 
was used to determine whether there were any statistically significant differences between 
the means of three or more independent (unrelated) groups. The experiments were run in 
triplicates from biologically identical bacterial sources. This assured the normality 
distribution assumption of ANOVA and prevented Type 1 errors to occur. Larger 
microbial probe and sample numbers may strengthen further the results of adhesion and 
biofilm studies. However, practical issues in the laboratory work may limit the 
experimentation possibilities. In this thesis, the use of technical triplicates allowed studies 
of bacterial adhesion and biofilm formation to be performed with sufficient precision and 
confidence.
Many aspects of the bacterial adhesion and biofilm formation remains unknown. 
Comparisons of results between in vitro and in vivo studies has limitations, due to the 
uniqueness of the human body as a system. Moreover, the conditioning films established 
in vivo on the implant surfaces are diverse and difficult to mimic. If a given biomaterial is 
microbe-repellent in vitro, it does not straightforwardly mean it will inhibit bacterial 
adhesion equally well in vivo. When investigating the influence of certain surface property 
on bacterial adhesion and biofilm formation, it is difficult to define confounding factors 
and to obtain adequate information about them because many properties are interrelated. 
Considering the concept of competition for the surface between host tissue and bacteria, 
discussed earlier in this thesis, a co-culture model in vitro might better reflect with in vivo
conditions. 
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As this thesis concentrates on the medical use of biomaterials in the human implants, 
serum incubations, and dynamic flow testing were used as methods to create in vivo
reminiscent conditions. The static bacterial adhesion and biofilm experiments were done 
in the presence of serum, which significantly affects the binding of bacteria (Patel,JD, et 
al. 2007). Proteins have sometimes been seen as confounding factors disturbing the "pure" 
bacterial adhesion; hence buffers such as PBS have been often used as media. However, 
in the human body, the implant surface is always covered with proteins derived from 
plasma, and ECM (Francois,P, et al. 1998). At the time of experimentation, serum 
incubation was a novel method in adhesion and biofilm studies. In the recent published 
studies, incubation with serum is well-established method in material science.
Both a reference bacterial strain and a clinical isolate were employed as 
microbiological probes. The use of a reference strain enables reproduction of the 
experiment by other researchers and comparison to existing studies. These reference 
strains are laboratory-adapted strains that lose genes due to several passages on the culture 
medium and can have lower genetic load than clinical strains. A clinical isolate may 
behave differently and possess different properties compared to the collection strain. The 
bacterial species tested in this thesis, S.aureus or S.epidermidis, are pathogens the most 
frequently implicated in implant infections. However, the taxonomic diversity of different 
bacterial species and strains is manifested in behavior of different bacteria resulting from 
unique surface proteins and structures. Therefore, the results of the study may not be valid 
in all strains and species.
Titanium and tantalum are biomaterials traditionally utilized in orthopedics. 
Chromium is widely used as a biomaterial component in cobalt-chromium-vanadium and 
surgical steel alloys but has no use in clinical practice as pure biomaterial due to 
carcinogenic and allergic properties (Barceloux,DG. 1999). It should be noted, that the 
results of this study are valid for DLC and DLC polymer hybrid coatings discussed earlier 
in chapter 2.1.4.2. In the literature, DLC is often used as an "umbrella" term referring to 
amorphous carbon coatings with "diamond-like" properties, which have many different 
fractions of diamond sp3-bonds and varying hydrogen content in the film. The quality of 
these amorphous carbon coatings is variable and therefore is reported not consistently. 
The DLC and DLC-p-h coatings produced with the FPAD method and described in this 
thesis have a high fraction of sp3 diamond bonds (>80%) (Alakoski,E, et al. 2003, 
Anttila,A, et al. 1999).
6.2 Bacterial adhesion (Studies I and II)
Both static and dynamic flow conditions were used to investigate bacterial adhesion. 
Dynamic flow conditions reflect circulation in the human body and the presence of tissue 
fluids. Common bacterial species were used in testing, and DLC and DLC-p-h were 
compared to commonly used biomaterials. Quantitative data describing bacterial adhesion 
was obtained in the experiments. 
In the static adhesion study, uniform binding of bacteria to un-patterned coatings was 
observed. When the biomaterial coating covered 69.4% of the total surface area (when Si 
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formed the spots on titanium background), the bacteria adhered homogeneously to the 
surface. Such localization reflects the fact that biofilm formation begins with adhesion of 
planktonic bacteria evenly to the surface what is typical for bacterial growth from 
homogenous suspension. If 30.6% of the surface area was covered by bacteria-binding 
biomaterials, the microbes formed in 90 minutes small biofilm-like bacterial communities. 
This demonstrates that bacteria divide and earlier start to produce EPS, also called slime. 
Microorganisms also grew on the silicon background with the smallest patterned spots, 
?????????????????????????? ????????????????????????????????????????????????????????????????????
covered area by five μm spots is the same as this covered by larger spots. Since the 
????????? ??? ??????????????? ??? ?????????????? ???? ???? ???? ???? ????????? ????? ??????
???????????????????????????????????????????????????????????????????????????????????????
spots. One could also think that the EPS matrix might form bridging connections with 
closest biomaterial spots -"islands." It is likely that these connections form a layer 
allowing microbes between the spots to avoid a contact with silicon background and make 
contact with the bacterial slimy layer covering the silicon background. 
In dynamic adhesion tests, the contact angles of the tested materials were measured to 
evaluate the effect of material surface hydrophobicity on bacterial adhesion. Within the 
conventional biomaterials, tantalum being the most hydrophilic metallic biomaterial had 
the lowest contact angle, followed by titanium and chromium, which was the most 
hydrophobic metallic biomaterial. This ranking order was similar to their ability to inhibit 
bacterial adherence of both S.aureus and S.epidermidis. This result confirmed the previous 
published findings that hydrophilicity is connected to the inhibition of bacterial adhesion, 
whereas hydrophobicity is related to good bacterial adherence to surface of biomaterial. 
In case of the DLC and its polymer hybrids DLC-PTFE-h and DLC-PDMS-h there 
were no associations between hydrophilicity and bacterial adhesion inhibition ability. 
DLC-PTFE-h and DLC-PDMS-h were the most hydrophobic materials with equally high 
contact angles, but DLC-PTFE-h inhibited bacterial adhesion in dynamic conditions best 
of all tested materials. Dynamic adhesion results show that hydrophobicity is not the only 
determining factor in the bacterial adhesion process. 
It could be hypothesized that the relationship between adherence and hydrophobicity 
might follow the same pattern as has been shown for the relationship between adherence 
of bone marrow-derived mesenchymal stromal cells and hydrophobicity. Stromal cells 
adhere better to materials with an intermediate contact angle than to more hydrophilic or 
hydrophobic surfaces. The turning point of this parabolic relationship for these cells is 
around the contact angle 60?(Shin,YN, et al. 2008). But this parabolic relationshipaxiom 
can not explain why DLC–PTFE-h had the lowest S. aureus binding ability whereas the 
DLC–PDMS-h surface with the same contact angle (104?) bind the highest number of S. 
aureus cells. Observations made in the dynamic testing agree with the conclusions made 
by Raulio et al. and Jones et al. (Jones,DS, et al. 2006, Raulio,M, et al. 2008). 
The measured sliding angles of DLC, DLC-PTFE-h, and DLC-PDMS-h did not 
correlate with their contact angles in dynamic adhesion study. It was seen that both DLC 
polymer hybrids had the same contact angles, but their sliding angles were different. 
Similar findings were reported by Kiuru and Alakoski (Kiuru,M and Alakoski,E. 2004)
and Chen et al. (Chen,W, et al. 1999).
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Surface roughness is biomaterial surface property often evaluated in bacterial adhesion 
and biofilm studies. After thin film deposition the surface roughness values of the samples 
in the static S.aureus experiments were below 10 nm. In the dynamic adhesion study, the 
surface roughness values of the samples were in a very narrow range between 2 and 25 
nm. According to the previous findings (Bollen,CM, et al. 1996), material surface
roughness values in these size ranges do not play any critical role in results of the 
experiments. The observed differences in surface roughness do not contribute to 
confounding factor nor offer any explanation for the test results.  Significant Ra values
affecting biofilm retention would be in the range of 200 nm or higher (Bollen,CM, et al. 
1996, Quirynen,M, et al. 1996)
The results of static adhesion testing differ from those obtained under dynamic 
conditions. Flow conditions affect behavior and surface structures of bacteria and this may 
explain these differences. The static experiments were done in the presence of serum, 
which signficantly affects the binding of bacteria (Patel,JD, et al. 2007). Adhesion of 
bacteria   in vivo is very complex phenomenon and optimal model has not been yet found. 
Presently, no single straightforward explanation for our adhesion results could be 
proposed. The outcome might be related to the sp3, and sp2 ratio in DLC material coatings 
or other bacteria-biomaterial interaction property such as zeta potential or other yet 
unknown factors. The sp3 and sp2 hybridized carbon-carbon bond ratios in DLC materials 
affect their properties (Lifshitz,Y. 1999), which might have an influence on the 
experimental results. Sp3 and sp2 bond ratios in our tested new DLC-p-h materials are not 
very well known yet. 
6.3 Biofilm formation (Study III)
Serum incubations were used in the biofilm study to create in vivo reminiscent 
conditions. Common bacterial species and biomaterials currently applied in clinics were 
chosen for testing. This study not only examined the ability of the biomaterial surface to 
inhibit biofilm formation, but also the retention of biofilm on the surface and the ability 
of the surface to allow detachment of biofilm. During the experiment, when biofilm 
covered samples were washed with 0.9% NaCl, an unknown amount of bacteria and 
biofilm detached from the surface, as an air-liquid interface was formed. An air-liquid 
interface associated with bacterial biofilm assays (Gomez-Suarez,C, et al. 2001), and the 
dynamic equilibrium between the forces of biofilm retention and removal (Quirynen,M 
and Bollen,CM. 1995), are evaluated in the literature.
It has been thought that high-energy surfaces bind bacteria and allow biofilm formation 
more than low-energy surfaces (Quirynen,M and Bollen,CM. 1995, Teughels,W, et al. 
2006) and hydrophobicity has been associated with inhibition of bacterial adhesion 
(Roosjen,A, et al. 2006, Tang,H, et al. 2009).  Though controversial data exists showing 
that hydrophobic surfaces allow more adhesion (Cerca,N, et al. 2005, MacKintosh,EE, et 
al. 2006, Patel,JD, et al. 2007). Both conclusions might be true, as is suggested by Baier 
(Baier,RE. 2006). Baier has studied the relationship between surface free energy and 
particulate or bacterial adhesion and proposed a curve as an explanation. He concluded 
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that there is an optimal value (around 25 mJ/m2) of surface free energy for minimal 
bacterial adhesion  (Baier,RE and DePalma,VA. 1971). According to parabolic curve, 
surface free energy values under and above the optimal value give enhanced bacterial 
adherence. This paradigm is described as Baier’s curve (Baier,RE and DePalma,VA. 1971, 
Baier,RE. 1980, Baier,RE, et al. 1984, Pereni,CI, et al. 2006). This has relevance to the 
results of Study III, where it was found that  the best material to inhibit biofilm formation 
was DLC-PTFE-h with a surface free energy of 24.5 mJ/m2. If only hydrophobicity of the 
material surface were considered, one would think that the low surface free energy and 
high contact angle materials DLC-PTFE-h and DLC-PDMS-h would be the best, but as 
described before, bacterial adhesion and biofilm formation are multifactorial processes, 
and other factors also may play a role. 
The zeta potential values of all materials were in a narrow range of -43.6 mV to -54
mV after serum incubation, indicating repulsive interactions between the negatively 
charged material surfaces and the bacterial slime.  For the two best biofilm formation 
repelling materials, DLC PTFE-h and DLC the zeta-potential values measured before 
serum incubation and the lowest recorded, were -84.2 mV and -88.4 mV respectively. 
After serum incubation, they were less negative and closer to the level of the values of the 
other materials analysed in this study. An increase from -84.2 mV to -48.8 mV was 
observed for DLC-PTFE-h and from -88.4 mV to -52.3 mV for DLC.  Other materials 
showed smaller changes in their zeta potential values. It could be suggested that the more 
noticeable change of zeta potential values of DLC-PTFE-h and DLC surfaces might be 
associated with their different charge and an amount of the proteins coating on the DLC-
PTFE-h and DLC surfaces as compared with other materials. 
In serum, proteins differ extensively in their charge and electrokinetic properties. 
Despite similar zeta-potential values after serum incubation, it is likely that the 
conditionings films on materials differ from each other in the type and conformational 
changes of the adsorbed proteins (Buchanan,LA and El-Ghannam,A. 2010). The size and 
quantity of the protein film, as well as the quality and conformation of adsorbed proteins, 
vary on different surfaces. The conformation of adsorbed proteins and ligands exposed to 
the body and bacteria are influenced by the material surface chemistry characteristics, as 
has been examined before (Baugh,L and Vogel,V. 2004, Keselowsky,BG, et al. 2003). 
Biomaterial surface chemistry has long-term effects on biofilm formation in the presence 
of serum proteins, as seen in the work done by Patel et al. with S.epidermidis (Patel,JD, et 
al. 2007). 
Two biomaterial properties, low surface energy and low zeta-potential affecting the 
conditioning protein film may explain inhibition of biofilm formation and poor retention 
of biofilm on DLC and DLC-PTFE-h. As these two materials were clearly the best in the 
study, it seems that the zeta-potential of the surface may play the main role because 
changes of DLC and DLC-PTFE-h electrokinetic potentials were different from changes 
of DLC-PDMS-h and other materials in the study. The difference between the two best-
performing biomaterials in the biofilm study might relate to hydrophobicities of the 
surfaces as DLC-PTFE-h surface is more hydrophobic than DLC surface (water contact 
angles 106? and 67.4?, respectively). The conditioning film derived from incubation with
serum affects biofilm formation, as it changes the zeta potential and contact angle values 
of the tested biomaterials. It has been reported that cell-to-cell binding and cell-to-matrix 
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adhesion is even more important for the biofilm formation than binding through 
physicochemical attraction forces (Cerca,N, et al. 2005, MacKintosh,EE, et al. 2006). 
Biofilm formation is thus affected not only by chemical and physical characteristics of the 
biomaterial surface but also by the adhesion molecules on the bacterial surface and the 
serum-derived counter-ligands on the biomaterial surface (Cerca,N, et al. 2005). 
Regarding surface roughness values of the tested biomaterials in the biofilm study, the 
samples had Ra values of equal or less than 2 nm and a smooth mirror quality comparable 
to the mirror finish surfaces of medical implants.
Recently, it has even been shown that super hydrophobic and super hydrophilic 
surfaces can both decrease biofilm formation. As an example, a lotus leaf has a water 
contact angle of 170º, low surface energy and specific surface roughness with 
microprotrusions and nano hairs with excellent self-cleaning properties (Zhang,X, et al. 
2013).  The development of super hydrophobic (Zhang,X, et al. 2013) and super 
hydrophilic (Mi,L and Jiang,S. 2014) materials has been gaining more interest in material 
sciences.
One can find in the literature many different explanations of the bacterial adhesion 
results and biofilm studies. The single factors or material/surface properties such as 
hydrophobicity, topography, surface charge, roughness, and chemistry have been 
examined for years. Super-hydrophobic surfaces, super-hydrophilic surfaces, negatively
charged surfaces and nm-scale surface roughness have all been shown to decrease 
bacterial adhesion. However, as bacterial adhesion and biofilm formation have become 
better known as complex phenomena, it is the most likely that several factors and 
properties might play a role. The results of the studies in this thesis lead to similar 
conclusions. This can also be confirmed by of in vitro studies performed with different 
experimental settings showing contradictory results (Cerca,N, et al. 2005, Patel,JD, et al. 
2007, Roosjen,A, et al. 2006, Tang,H, et al. 2009). 
Live/Dead staining of biofilm was used to visualize bacteria clustered in the slimy EPS 
matrix; especially the viability of the bacteria was screened. Live/Dead stainings showed 
that the viable (stained green) bacteria were located in the proximity of the biofilm surface 
while the dead (stained red) bacteria were situated in the interior and bottom of the 
mushroom-like biofilm towers. The explanation for this could be that nutrients and oxygen 
diffuse with difficulties to the deeper sectors of the biofilm. The bacteria located deep in 
the biofilm might die of starvation because the top surface localized microbes might use 
much of the nutrients. Patel et al. also viewed the biofilm after Live/Dead staining and 
reported similar findings (Patel,JD, et al. 2007)
6.4 hBD-3 in septic implant loosening (Study IV)
The cellular sources of origin of hBD-3 in septic joint implant loosening were 
described. According to past studies, hBD-3 can be found in the synovial fluid in septic 
implant loosening. The concentrations of hBD-3 were shown to be even higher in synovial 
fluid than in serum (Gollwitzer,H, et al. 2013), suggesting local production and secretion 
of hBD-3 in peri-implant tissues in septic loosening. An increased mean optical density of 
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hBD-3 was observed in periprosthetic tissues of septic loosening patients compared with 
aseptic loosening patients, the spacer group, and normal controls in hBD-3
immunostaining (Liu,GD, et al. 2014). This indicates that the intensity of hBD-3 staining 
of positive cells or the proportion of the hBD-3 immunoreactive cells was increased, what 
indicates a local synthesis and release of hBD-3 in septic loosening. The results of this 
thesis explain the increased tissue and synovial fluid concentrations of hBD-3 in septic 
implant loosening.
The heterogeneous and local expression of hBD-3 in peri-implant tissues in septic 
implant loosening is consistent with the findings showing that the hBD-3 is absent in 
healthy synovial tissues. The hBD-3 has been found in synovial membranes of 
osteoarthritis, psoriatic arthritis (Paulsen,F, et al. 2002) and rheumatoid arthritis 
(Bokarewa,MI, et al. 2003) patients without any clear links to an infection. Since hBD-3
was not found in healthy synovial membranes (Paulsen,F, et al. 2002) the upregulation of 
hBD-3 may be inflammation-related. Instead, hBD-1 is present in the healthy synovial 
membrane. Moreover, hBD-3 may also describes the severity of the infection and 
inflammation in periprosthetic tissues in PJIs (Gollwitzer,H, et al. 2013, Liu,GD, et al. 
2014). 
Less sensitive indirect immunofluorescence method may not show minor 
immunoreactive hBD-3 accumulations related to fibroblasts and foreign body giant cells. 
This is in agreement with the reports that the modern multilayer methods such as 
peroxidase-anti-peroxidase complex (and avidin-biotin-peroxidase complex method) 
(Moran,MM, et al. 1985) have been shown to be 100 -to 1,000-fold more effective than 
indirect immunofluorescence in immunodetection. These modern methods allow 100 -to 
1,000-fold higher dilutions of primary antibodies (Beckett,JH and Bigbee,JW. 1979). The 
horseradish peroxidase labeled polymer method used in the study of this thesis also is two 
to fivefold more sensitive compared to multilayer methods mentioned above (Sabattini,E, 
et al. 1998). Nevertheless, a minor role for fibroblast as a potential cellular source of hBD-
3 in synovial fluid and peri-implant tissues in septic loosening is suggested, but remains 
controversial (Dunsche,A, et al. 2002). The very low amount of hBD-3 seen in labeled 
polymer stained fibroblasts might relate to exogenous hBD-3 bound (Nishimura,M, et al. 
2004) or taken up (Semple,F and Dorin,JR. 2012) by fibroblasts. Neutrophils and mast 
cells, cells equipped with storage granules, were hBD-3 negative in this current study.
Regulation of hBD-3 in septic loosening was further analyzed in different sub-groups. 
The analysis suggested that the expression of hBD-3 is differently regulated in women and 
men. It is likely that this difference is more related to differences in the anatomy and 
implant loading than sex steroid effects on host response, considering that the study group 
have older patients. The presence or absence of staphylococci did not relate to the host 
hBD-3 response. This might be due to hBD-3 regulation by a variety of PAMPs and tissue 
derived DAMPs. The histology of the peri-implant tissues was associated with the survival 
time of the implants, which might be  related to mechanisms of tissue pathology.
In septic loosening the locally produced hBD-3 probably functions as a site- and time-
specific effective anti-microbial agent, host defense molecule (Dhople,V, et al. 2006, 
Wang,G. 2014). It has efficacy against staphylococci, the micro-organisms most often 
implicated in PJIs (Arciola,CR, et al. 2012, Montanaro,L, et al. 2011) and even against 
MRSA. Additionally, hBD-3 has activity against Gram-negative bacteria and fungi 
  87 
 
 
 
(Feng,Z, et al. 2005, Harder,J, et al. 2001). hBD-3 has thus broader antimicrobial capacity 
in contrast to hBD-1 and hBD-2, which are active against Gram-negative bacteria and 
some fungi. Considering that hBD-3 binds broadly to several microbes, it might offer 
potential in medical imaging and as a diagnostic asset in the detection of septic implant 
loosening (Leung,K. 2009). 
Regarding limitations of the current study of this thesis, the sample number was low. 
This means that the subgroup analysis by age, gender, the location of the implant, type of 
the pathogen and the survival time of the implant are not definite and need to be examined 
further with larger patient and sample series. Secondly, hBD-3 was localized by using only 
immunostaining. Other methods would have strengthened the demonstration of hBD-3 in 
different cell types in septic loosening. Nevertheless, the specificity of the immunostaining 
was confirmed by sample and staining controls. 
6.5 Clinical implications and future perspectives
The complexity of the bacterial interactions, the ability of bacteria to persist in the 
extreme environments and antibiotic resistance, are main challenges in the prevention of 
implant infections. The high degree of genomic diversity among bacterial strains and 
species and the difficulties of translating animal models to human trials have hindered the 
progress in therapeutical solutions. In this thesis, an approach for fighting infections is 
provided in the form of coatings that could minimize bacterial adhesion and biofilm 
formation on a biomaterial surface. 
DLC and its new polymer hybrids DLC-PTFE-h and DLC-PDMS-h were tested 
against conventional biomaterials used in medical implants regarding their ability to 
inhibit bacterial adhesion and biofilm formation. The DLC inhibited bacterial adhesion in 
static conditions and biofilm formation better than conventional implant materials. It was 
as good as conventional implant materials in dynamic flow testing of bacterial adhesion. 
The novel and anti-soiling DLC-PTFE-h was as good as conventional implant 
biomaterials when bacterial adhesion was tested in flow conditions, but showed the 
highest resistance to biofilm formation. 
According to the current studies, DLC and DLC-PTFE-h are microbe-repellent 
biomaterials and could be utilized to combat implant infections. Due to its mechanical 
properties such as hardness and wear resistance, DLC could be applied as a coating for 
orthopedic implants. DLC-PTFE-h could be utilized in medical devices, e.g. guidewires, 
cardiac catheters and artificial heart valves to prevent implant-related infections. The 
obtained results could not be explained solely by the measured biomaterial 
physicochemical surface properties. 
The cellular sources of origin of hBD-3 antimicrobial peptide were identified in peri-
implant tissues in septic implant loosening. Given the unique role of hBD-3 as a powerful 
natural antibiotic against even multiresistant (Maisetta,G, et al. 2006) and naturally 
tolerant (Gottlieb,CT, et al. 2008) bacterial strains, it seems that the pharmaceutical field 
will explore more the possible utilization of hBD-3. As the broad use of antibiotics is 
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associated with resistance and adverse effects, alternative treatment strategies such as the 
hBD-3 should be studied further.
In future study experimentation efforts should be made to mimic in vivo conditions 
even more extensively, and in vivo animal experiments would be essential to obtain 
information relevant to clinical practice.  The diversity of the microorganisms warrants 
multiple pathogens as testing probes and using wild-type clinical isolates are of great 
importance. When the effect of biomaterial surface properties on bacterial adhesion and 
biofilm formation is assessed, several parameters should be taken into consideration. In 
the future, the emphasis in the research efforts should be laid on the competitions between 
bacteria and tissue cells for the free implant surface. In such studies, simultaneous growth 
of bacteria and tissue cells on the same biomaterial surface is evaluated. 
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7. CONCLUSIONS
Study I. Under static conditions and in the presence of serum proteins, the DLC was 
more microbe-repellent than conventional biomaterials. Micropatterned surfaces are 
useful for quantitative evaluation of bacterial adhesion on biomaterials. Different sized 
microtextures enable data collection regarding bacterial alignment and colonization on 
surfaces. 
Study II. The DLC and DLC-PTFE-h were as good as conventional biomaterials in 
their ability to inhibit bacterial adhesion under dynamic flow conditions. The DLC-PDMS 
bound significantly more S.aureus than DLC-PTFE-h and tantalum. 
Study III. The DLC and DLC-PTFE-h were more resistant to biofilm formation than 
conventional biomaterials and DLC-PDMS-h in the presence of serum. The DLC-PDMS-
h was as good as conventional biomaterials in its ability to inhibit biofilm formation. The
DLC-PTFE-h excelled the anti-biofilm ranking..
Study IV. The cellular sources of the antimicrobial peptide hBD-3 in peri-implant 
tissues in septic implant loosening are mainly macrophages and vascular endothelial cells. 
The hBD-3 was not found in neutrophils or mast cells. The heterogeneous topological
expression of hBD-3 in peri-implant tissues in septic implant loosening designates local 
induction, which is well in line with earlier findings in the literature.
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